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Part of a Scientific Master Plan?
Paul Ehrlich and the Origins of his
Receptor Concept
CAY-RUDIGER PRULL*
Oneofthebasictheoriesoftwentieth-century scientificmedicineisthereceptorconcept.
Itdealswiththequestionofhowinformation canbe submitted tothecell. Receptors canbe
described as "small, discrete area(s) on the cell membrane or within the cell with which
molecules or molecular complexes (for example, hormones, drugs, and other chemical
messengers)interact".1 Thereceptorconceptbecameincreasinglyimportant,especiallyfor
pharmacology, as it explained the binding of drugs to cells and drug-effects on specific
tissues and organs.
The origins of the receptor concept stem from the last third of the nineteenth century
and are chiefly connected with two names: Paul Ehrlich (1854-1915) and John Newport
Langley (1852-1925). Remarkably, these two scientists approached the receptor idea on
significantly different routes and from different backgrounds: John Newport Langley,
professorofphysiologyinCambridge, waspredominantlyconcernedwiththeinvestigation
ofthe functions ofthe autonomic nervous system, i.e. ofthose nerves whichregulate, with-
out our conscious influence, the vegetative functions ofthe body, such as blood-pressure
and respiration. Paul Ehrlich, the Berlin bacteriologist and immunologist, was keen to
examine therelations betweenbacterial toxins and antitoxins and to supportcontemporary
efforts to combat infectious diseases. Both mentioned the idea first in 1878, and both
returned to theirformerapproaches only several years later-at the turn ofthe nineteenth to
thetwentieth century. According to ourcurrentknowledge aboutthehistoryofthereceptor
concept, the two scientists developed their initial ideas on receptors independently.2
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This paperfocuses onPaulEhrlich andthedevelopment ofhis receptorconceptbetween
1878 and approximately 1905, when the concept was brought to a certain conclusion.
The purpose is to deal with a basic problem: as there are two independent approaches
to the subject, one could assume thatreceptors are "objective" facts ofnature and that the
"discovery" ofthe receptors was somehow "inevitable". This impression contrasts with
the sociological constructivist interpretation of science: discoveries do not neatly corres-
pond to objective entities in nature. They are dependent on the cultural setting, for
example, the social position of the researcher and the local scientific system.3 This
paper will show that the constructivist view can be helpful in understanding Ehrlich's
"discovery" ofthereceptorconcept asthe latteremergedfromthedualeffectofsocial and
scientific aspectsofhisbiography. ThismeansthatalthoughtherootsofEhrlich'sideascan
betracedbacktoearlystagesofhiscareer, althoughhisideasappearedinalogicalorderand
althoughhewasdrivenbyaleitmotifthroughouthisacademiclife,itwasfarfromclearwhy
and how he would develop the receptorconcept. My analysis provides some insights into
the history ofmodem medical science andcontributes to ourunderstanding ofthe receptor
concept's position inearly twentieth-century medicine. Inthis contextitis notmy purpose
to follow up the history of the usage of Ehrlich's concept in pharmacology. By contrast,
Ienvisage thispaperas acontributionto the analysis ofthe difficult startingpositionofthe
receptor idea. Its birth and its character contain the roots ofproblems, which caused many
difficulties in the successful introduction of the idea to pharmacology after 1945.
I will first discuss Ehrlich's basic scientific ideas and the traditional views on his aca-
demiclife. ThenIwillgointomoredetailandtakeacloselookatEhrlich'scareerinrelation
to his work on receptors. Finally, I will summarize and evaluate my findings.4
The Roots ofEhrlich's Research and the Inevitable Discovery of the Receptors
In any focused analysis of Ehrlich's ideas, the introduction of his receptor concept
appears to be consistently planned and realized. As a medical student at the universities
of Strasbourg and Breslau he concentrated on the staining of histological specimens.
Breslau becameespecially important: hewasinfluencedabove allbythepathologistJulius
Cohnheim(1839-1884), oneofthefewGermanpathologists touseanimalexperimentation
in addition to pathological anatomy.5 Cohnheim's research into pathological function, in
3For the constructivist view of the history of
science, see Jan Golinski, Making natural knowledge:
constructivism and the history ofscience, Cambridge
University Press, 1998; Timothy Lenoir, Instituting
science: the culturalproduction ofscientific
disciplines, Stanford University Press, 1997.
4This paper makes use of the printed works of
Ehrlichbetween 1878 and 1905, which canbe foundin
Fred Himmelweit (ed.), with the assistance ofMartha
Marquardt, under the editorial direction of Sir Henry
Dale, The collectedpapers ofPaul Ehrlich infour
volumes including a complete bibliography, vol. 1,
Histology, biochemistry andpathology, vol. 2,
Immunology and cancer research; vol. 3,
Chemotherapy, London and New York, Pergamon
Press, 1956-60; and of parts ofEhrlich's unpublished
estate,hislaboratorybooks,hislaboratorynotesandhis
correspondence in the Paul Ehrlich Collection,
Rockefeller University Archives at the Rockefeller
Archive Center in New York (hereafter RUA, RAC).
Thepaperalsoconsiders materials fromtheArchive of
the Humboldt-University in Berlin and from the State
Archive of Prussian Cultural Heritage (Geheimes
Staatsarchiv PreuBischer Kulturbesitz, hereafter GStA
PK), Berlin.
5Ernst Baumler, Paul Ehrlich. Forscherfir das
Leben, 3rd ed., Frankfurt am Main, Wotzel, 1997, pp.
24-30, 31-6; Ernst Jokl, 'Paul Ehrlich: man and
scientist', Bull. N. Y. Acad. Med., 1954, 30: 968-75,
esp. p. 972; Margaret Goldsmith, 'Paul Ehrlich',
in Hector Bolitho (ed.), TwelveJews, London, Rich &
Cowan, 1934, pp. 65-81, esp. p. 69.
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contrast to pathological morphology, was accompanied by close contacts with clinicians.
He also influenced many British medical students and contributed in this way to the
introduction of "clinical pathology" into Britain.6 Under his influence, Ehrlich followed
thepathofapplyinglaboratoryfindingstoclinicalpracticeand, infact,became apioneerof
clinical pathology in Germany.
Ehrlich's basic scientific ideas can bebriefly summarized: first, he made aclaim forthe
routine application of the method of staining to medicine in general and to histology in
particular. Second, he supported the theory that the staining process relied on a chemical
reaction between dye-stuff and cell.7 These two ideas formed the basis or leitmotif of
Ehrlich's side-chain and then receptor theory. As early as 1878 Ehrlich had written in
his dissertation of "a definite chemical character ofthe cell"8 which was necessary for its
reactionwithadye. In 1897, almostnineteenyearslater,whenheworkedonimmunological
problems, Ehrlich returned to this point and developed his chemical "side-chain theory".
Certain "side-chains" ofthe cell were able to bind certain toxins. Because these occupied
side-chains wouldthenbecomeunabletofulfiltheirphysiological functions, thecellwould
overcompensate byproducing alotofadditional side-chains, which wouldbereleasedinto
the blood-stream, where they acted as antibodies or antitoxins.9 Against this background,
in 1900, Ehrlich introduced the term "receptor" as adesignation ofthe side-chain's func-
tion.10 In 1908, Ehrlich was awarded the Nobel Prize for his work in immunology.
A shiftinthinking enabled Ehrlich toapply his concept todrugbinding. Hefirstthought
receptors wouldbindtoxines andnutritive substances only. Manydrugs couldbe extracted
from tissues easily and so they seemingly could notbe bound firmly to the cell. Therefore
theycould notevoketheproduction ofside-chains." Ehrlich'stheory allowed-as afuture
perspective-drug binding to cells only indirectly, as he proposed that certain chemical
bodies orgroups (Korperklassen) with specific binding capacities to specific organs could
be used as "vehicles" (Lastwagen) to carry artificial substances to the site ofeffect.12 Not
before 1907-with reference to his own work on the effect ofdyes on trypanosomes and
6Cay-Rudiger Priill, Medizin am Toten oder am
Lebenden?PathologieinBerlinundinLondon1900bis
1945, Freiburg, 1999, Habilitation thesis, Basle,
Schwabe, forthcoming; esp. pp. 389-92; Russell C
Maulitz, 'Rudolf Virchow, Julius Cohnheim, and the
program ofpathology', Bull. Hist. Med., 1978, 52:
162-82.
7Conceming Ehrlich and chemistry, see Henry
Hallett Dale, 'Introduction', in Himmelweit (ed.), vol.
1, op. cit., note4above, pp. 1-18, esp. p. 2; Goldsmith,
op. cit., note 5 above, pp. 69-70.
... . eine bestimmte chemische Beschaffenheit
der Zelle selbst . . .", in Paul Ehrlich, Beitrage zur
Theorie und Praxis der histologischen Farbung,
Thesis, Leipzig University, 1878, in Himmelweit (ed.),
vol. 1, op. cit., note4above, pp. 29-64, Englishtransl.:
ibid., pp. 65-98. See the quotation on p. 40 (German
original); p. 75 (English transl.).
9Paul Ehrlich, 'Die Wertbemessung des
Diphtherieheilserums und deren theoretische
Grundlagen' (Klinisches Jahrbuch, 1897), in
Himmelweit (ed.), vol. 2, op. cit., note 4 above,
pp. 86-106, English transl. pp. 107-25. For a
contemporary description ofEhrlich's side-chain
theory, see Ludwig Aschoff, Ehrlich's
Seitenkettentheorie und ihre Anwendung aufdie
kunstlichen Immunisierungsprozesse, Jena, Fischer,
1902, esp. pp. 1-25. See also Bruno Heymann, 'Zur
Geschichte der Seitenkettentheorie Paul Ehrlichs',
Klin. Wochenschr., 1928, 7: 1257-60; Arthur M
Silverstein, A history ofimmunology, San Diego
and New York, Academic Press, 1989, esp.
pp.64-6,94-9.
l°Paul Ehrlich and Julius Morgenroth, 'Ober
Haemolysine. Dritte Mittheilung' (Berliner Klinische
Wochenschrift, 1900), in Himmelweit (ed.), vol. 2,
op. cit., note 4 above, pp. 196-204, English transl.
pp.205-12.
1 JohnParascandola, 'The theoretical basisofPaul
Ehrlich's chemotherapy', J. Hist. Med. Allied Sci.,
1981, 36: 19-43, esp. p. 28.
12Paul Ehrlich, 'Uber die Beziehung von
chemischer Constitution, Vertheilung und
pharmakologischer Wirkung', from Internationale
Beitrage zur inneren Medizin: Festschriftfiur Ernst v.
Leyden zur Feier seines 70.jahrigen Geburtstages
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Langley's notion of "receptive substances"-did Ehrlich accept the binding of drugs to
receptors.13Forthispurposetherewouldbespecific "chemoreceptors".Thedrugneededto
have a greater affinity to the chemoreceptors ofthe invading organisms, for example the
trypanosomes, than to the chemoreceptors of the host's body. The concept of "specific
affinity" was applied to the pharmacological realm. Based on early nineteenth-century
investigations ofthe relationship between chemical composition and physiological action
ofcertaindrugs,14Ehrlichwasnowabletoexplainallthephenomenainconnectionwiththe
effectofachemotherapeutic drug,forexampledrugresistance, withthehelpofthereceptor
concept. The receptors became the theoretical basis for his subsequent work with the dye
"trypan red" and with the arsenic compound "atoxyl" to combat trypanosome infections,
ending with the discovery ofSalvarsan, the first chemotherapeutic substance for the treat-
mentofsyphilis, in 1910.15 Withthis discovery, Ehrlichbecame oneofthe mostprominent
figures of twentieth-century medicine.16
The development and realization ofEhrlich's theories quickly acquired the appearance
of an unbroken success story, taking three steps in a constituent order: staining-
immunology-chemotherapy.17 Of course, the hypothetical character of the side-chain
and receptor theory was soon acknowledged, but its development within the frame of
Ehrlich'slifeandcareerwasdescribedasanundisturbedhomogeneousprocessofmaturing,
sometimes asthe successive appearanceofsecretlypredevelopedplans. Thisinterpretation
didnotremainunchallenged, butit shapedthehistoriography onEhrlich's work.18 Even in
Ehrlich's own time,'9 the side-chain or receptor theory found its place in his celebrated
biography. In 1919, one of his students, Leonor Michaelis, was impressed by the newly
discovered dissertation of the master. It would be "of great value for the recognition of
Ehrlich's scientific development". According to Michaelis, the dissertation foreshadowed
am 20. April 1902, Berlin, Hirschwald, 1902, in
Himmelweit (ed.), vol. 1, op. cit., note 4 above,
pp. 570-95, esp. p. 595. English transl. pp. 596-618,
esp. p. 618.
13Parascandola, op. cit., note 2 above, pp. 134-41.
14See Williamn F Bynum, 'Chemical structure and
pharmacological action: achapterinthehistoryof19th
century molecular pharmacology, Bull. Hist. Med.,
1970,44:518-38.
'51Itisnotpossible inthispapertogive afull account
ofthehistory ofthe application ofthereceptorconcept
to drug binding and pharmacology. See, esp.,
Parascandola, op. cit., note 11 above, pp. 21,
30-3, 35.
16The best general account of Ehrlich's life is
Claude E Dolman, 'Paul Ehrlich', in Dictionary of
scientific biography, New York, Charles Scribner's
Sons, 1981, vol. 3, pp. 295-305. Dolman also gives an
overview of the literature on Ehrlich up to 1980.
Although eighty-six years have passed since his death,
the writing on Ehrlich remains largely hagiographic
(see, for example, Baumler, op. cit., note 5 above) for
several reasons. As Ehrlich was Jewish, all public
written testimonies ofhis life were erased by the Nazi
government after 1933. After the war, Ehrlich's estate
was not accessible for research until recently.
Furthermore, hagiographic accounts were presumably
promoted by the new scientific optimism of the post-
war decades, for example, Ernst Witebsky, 'Ehrlich's
side-chain theory in the light ofpresent immunology',
Ann.N. Y.Acad.Sci., 1954,59: 168-81. Forthehistory
ofresearch on Ehrlich, see Henry Hallett Dale,
'Introduction', in Martha Marquardt, Paul Ehrlich,
London, Heinemann, 1949, pp. xiii-xx; Dale, op. cit.,
note 7 above above; Baumler, op. cit, note 5 above,
pp. 5-9. The serious recent historiography of Ehrlich
includes mostly papers on specific aspectsofhis work.
17See, for example, Richard Koch, 'Vorwort', in
Martha Marquardt, Paul Ehrlich als Mensch und
Arbeiter. Erinnerungen aus dreizehn Jahren seines
Lebens(1902-1915), Stuttgart andBerlin,DVA, 1924,
pp. 3-15; Dale, 'Introduction', op. cit., note 16 above,
p. xvi.
'8See, for example, Jokl, op. cit., note 5 above,
p. 974; F Klose, 'Paul Ehrlich und Emil v. Behring.
Zurhundertjiihrigen Wiederkehr ihrer Geburtstage am
14. und 15. Marz 1954', Deutsche Med. Wochenschr.,
1954, 79: 425-27, esp. p. 425.
19See August von Wassermann, 'Die
Seitenkettentheorie', in Hugo Apolant et al., Paul
Ehrlich. Eine Darstellung seines wissenschaftlichen
Wirkens. Festschrift zum 60. Geburtstage des
Forschers (14. Marz 1914), Jena, Gustav Fischer,
1914, pp. 134-50.
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Ehrlich's whole oeuvre.20 Even today, Ehrlich's dissertation is sometimes regarded as the
masterplanofasuccessfulresearchprogramme.21 Recentpapersonhiswork, whichdonot
venture extensively into Ehrlich's biography andthecircumstances ofhislife, explicitly or
implicitly defend the view of a continuous path towards the receptors. Anthony S Travis
explains the development of the side-chain and receptor idea as an outcome of Ehrlich's
progressive work on dyes. Considering the "social frameworks" forhim means afocus on
Ehrlich's collaboration with the chemical industry. Timothy Lenoir's interpretation lies in
the same direction. Itfocuses onthepositionofEhrlich'sresearch onthe side-chains within
the triangle of science, politics, and industry. In 1999, Arthur M Silverstein drew a more
radical conclusion from his analysis of Ehrlich's "receptor immunology". According to
him, the receptor idea had been pursued by Ehrlich from his dissertation onwards for over
twenty years, i.e. upto 1898. Inhis monograph onEhrlich's receptorconcept, Silverstein's
argument is basically the same.22 The studies ofJohn Parascandola and Ronald Jasensky
aptly describe the ups and downs ofthe early receptortheory, but do notexplore its social,
historical and cultural context.23
A closer lookinto the development ofthe concept in the context ofEhrlich's biography
until 1905 shows us the impact of many more factors on the emergence of his idea. In
analysing Ehrlich's development ofthe receptortheory within the framework ofhis socia-
lization and academic career, five phases can be detected.
Paul Ehrlich's Scientific Career and the Emergence of his Receptor Concept
(1) Ehrlich as a Clinician, 1878-1888
In 1909, afewyearsbeforehisdeath, Ehrlichinformed afriendaboutthemostimportant
aspects ofhis scientific work. He pointed out that his greatest interest had always been in
active therapeutics andthatthecombination ofhischemicalandtherapeutic interestscould
explain hisentire scientificcareer.24In 1878, Ehrlich was appointed seniorphysician atthe
FirstMedicalClinicoftheCharite'-Hospital inBerlin. Theheadoftheclinic atthistimewas
the well-knownprofessorofinternal medicine, FriedrichTheodorFrerichs (1819-1885).25
... zur Erkennung der wissenschaftlichen
Entwicklung Ehrlichs sehr wertvoll", see Leonor
Michaelis, 'Zur Erinnerung an Paul Ehrlich: Seine
wiedergefundene Doktor-Dissertation', Die
Naturwissenschaften, 1919, 7: 165-8, esp. p. 165;
see also pp. 167-8.
21Maria Luise Eckmann, Die Doktorarbeit Paul
Ehrlichs und ihre Bedeutungffir die Geschichte der
histologischen Farbung, Thesis, Hamburg University,
1959; LizMarshall, 'PaulEhrlich. 1854-1915. German
bacteriologist and immunologist', in Emily J
McMurray (ed.), Kelly Kosek and Roger M Valade Ill
(assoc. eds), Notable twentieth-century scientists,
New York and London, Gale Research, 1995, vol. 1,
pp. 564-7, esp. p. 565.
22Anthony S Travis, 'Science as the receptor of
technology: Paul Ehrlich and the synthetic dyestuffs
industry', Science in Context, 1989, 3: 383-408;
Timothy Lenoir, 'A magic bullet: research for profit
and the growth ofknowledge in Germany around
1900',Minerva, 1988,26: 66-88;ArthurMSilverstein,
'Paul Ehrlich's passion: the origins of his receptor
immunology', Cell. Immunol., 1999, 194: 213-21;
Silverstein, op. cit., note 2 above.
23ParascandolaandJasensky, op.cit., note2above,
pp. 199-220; Parascandola, op. cit., note 2 above,
pp. 129-56. Also concentrating mainly on Ehrlich's
ideas, Anne-Marie Moulin, Le dernier langage de la
me'decine. Histoire de l'immunologie de Pasteur
au Sida, Paris, Presses Universitaires de France, 1991,
esp. pp. 74-97.
24Dale, op. cit., note 7 above above, p. 9.
25Franz Hermann Franken, Friedrich Theodor
Frerichs (1819-1885). Leben und hepatologisches
Werk, Freiburg, Falk Foundation, 1994; M Classen,
FHFranken,DGericke, 'FriedrichTheodorFrerichsin
Berlin', Deutsche Med. Wochenschr., 1995, 120:
1334-7.
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Frerichs wanted to integrate laboratory research and laboratory diagnostics into clinical
work in the wards, and he therefore supported Ehrlich's staining experiments.26 In the
following years, Ehrlich combined his work in the wards with his work at the laboratory
bench. He performed pathoanatomical studies, examining tissue specimens from the post-
mortem room to gain knowledge about the causes of patient deaths. The application of
stainingmethods helpedtoexplainthepathologically alteredfunction ofthemorphological
structures. Oneexampleofthisresearch isEhrlich's studyofglycogeninthehealthy andin
the diabetic human organism.27
Moreover, Ehrlich workedinthefieldofclinical pathology whenexaminingbody fluids
of living patients. One example is his study of bacteriological problems in the course of
pleuritic exudates (effusions into the pleural cavity) through consideration of the patient
records ofwomen in childbed. The application ofdifferent staining methods on microbes
allowed him to identify different infections. These results enabled him to give diagnostic
andprognostic advice.28 Furthermore, inthese yearsunderFrerichs, Ehrlichperformedthe
first biopsies ofthe liver on humans.29 Finally, he described the so-called Diazo-reaction
(Diazo-Reaktion) in 1883. This was a special urine test to detect bilirubin with the help of
dyes-a clinical test for patients with presumably heavy infections.30
Only occasionally did Ehrlich publish single clinical case histories, which show only a
marginal relation to his scientific work.31 Mostofthe papers written in theseclinical years
are concerned with the application of dyes, especially in animal experiments. In 1882,
Ehrlich examined fluorescent dyes on the eye of the rabbit, hoping to find a method to
diagnose human eye diseases. The effectiveness of the substance as well as possible side
effects were of interest.32 Ehrlich's experiments on blood were especially outstanding.
Following animal experimentation, different dyes were applied and tested on the blood of
sick andhealthy patients. Different kinds ofwhite and red blood cells were explored. This
experimental work was then applied to the diagnosis and therapy ofblood- and infectious
diseases. Ehrlichbecame apioneerinmodernhaematology.33 Furthermore, Ehrlich'searly
co-operation withthebacteriologist Robert Koch (1843-1910) reliedonthe use ofstaining
26Travis, op. cit., note 22 above, p. 393.
27Dolman, op. cit., note 16 above, p. 296; Paul
Ehrlich, 'Uber das Vorkommen von Glykogen im
diabetischenundimnormalenOrganismus' (Zeitschrift
fur klinische Medizin, 1883), in Himmelweit (ed.),
vol. 1, op. cit., note 4 above, pp. 103-12.
28Paul Ehrlich, 'Beitrage zur Atiologie und
Histologie pleuritischer Exsudate', (Charite'-Annalen,
1882), in Himmelweit (ed.), vol. 1, op. cit., note 4
above, pp. 29-310.
29Franken, op. cit., note 25 above, pp. 59-62.
30Paul Ehrlich, 'Uber eine neue Hamprobe',
(Charite'-Annalen, 1883), in Himmelweit (ed.), vol. 1,
op. cit., note 4 above, pp. 619-29; idem,
'Sulfodiazobenzol, ein Reagenz auf Bilirubin'
(Zentralblattfiur klinische Medizin, 1883), in ibid.,
pp. 630-1; idem, 'Uber die Sulfodiabenzol-Reaction'
(Zentralblattfur klinische Medizin, 1883), in ibid.,
pp. 632-42; idem, 'Nachtragliche Bemerkungen zur
Diazoreaction' (Charite'-Annalen, 1886), in ibid., pp.
643-5; idem, 'DieDiazo-undAzomethin-Reactionen',
draft, probably written in 1900, in ibid., pp. 646-50;
idem, 'Uber die Dimethylamidobenzaldehydreaction'
(Medizinische Woche, 1901), in ibid., pp. 651-3.
31 See, for example, a case study on phosphorous
poisoning: Paul Ehrlich, 'Uber einen Fall von
Phosphorvergiftung mit symmetrischer Gangraena
pedum' (Charite'-Annalen, 1882), in Himmelweit(ed.),
vol. 1, op. cit., note 4, pp. 526-9.
32Paul Ehrlich, 'Uber provocirte
Fluorescenzerscheinungen am Auge' (Deutsche
Medizinische Wochenschrift, 1882), in Himmelweit
(ed.), vol. 1, op. cit., note 4 above, pp. 344-53.
33Foranoverview, see PaulEhrlichandALazarus,
Histology ofthe blood, Cambridge University
Press, 1900 (rev. transl. of P Ehrlich and A Lazarus,
'Die Anaemie', in H Nothnagel, Specielle
Pathologie und Therapie, Vienna, Holder, 1898), in
Himmelweit (ed.), vol. 1, op. cit., note 4 above,
pp. 181-268.
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as an instrument to servepractical purposes. After 1882, when Kochhaddemonstrated the
newlyfoundtuberclebacillus,EhrlichimprovedKoch'sstainingmethodforthismicrobe.34
Ehrlich used dyes not only to solve problems ofdiagnosis but also to introduce them as
therapeutic agents. In 1886, the substance thallin wasusedonrabbits andshortly thereafter
onpatientssufferingfromtyphoidfever.Thebestdosagetocombatthefeversymptomswas
estimated, particularly at the climax ofthe disease. Ehrlich was able to give advice on the
clinical use of this substance.35
Ehrlich's profile ofdaily work enables us to estimate the impact ofthe receptorconcept
on his research at these times. The "side-chain" theory was the outcome of one specific
study-his habilitation thesis (teaching licence) of 1885, which was dedicated to Frerichs.
Onthebasisofcountlessanimalexperiments,Ehrlichwantedtoestimatethe "oxygen-need
oftheorganism" (Sauerstoff-Bediirfniss des Organismus). Thedyes servedhimtoindicate
the different degrees of oxygen affinity of the various organs. Following the infusion of
dyes, theanimals werekilledaftercertainintervalsoftime, anddissected. Thecolouring of
the tissues indicated the metabolic activities ofthe single organs and tissues and enabled
a certain classification. Ehrlich concluded that the inner part of the cell (protoplasm/
Protoplasma) was able to utilize oxygen. According to Ehrlich, the protoplasm had
side-chains, which could bind oxygen. This complex could be burned in the protoplasm
and transformed into energy. His study presented a theoretical basis forhis staining meth-
ods, but the side-chain as predecessor of the receptor played no important role in his
discussion of oxygen utilization. Moreover, Ehrlich focused on the organs, the character
oftheprotoplasm andofthe surrounding paraplasm(Paraplasma, moreunspecific areasof
the cell, die mehr indifferenten Territorien desZellenleibes) ofthe cell.36 The side-chains
are mentioned in Ehrlich's 69-page habilitation thesis (in Himmelweit's edition of the
collected works) only six times and then never again during the period of his work
under Frerichs.37
Ehrlich's major aim was to achieve clinically applicable results. He could influence the
workonthewardswhenconnectingdifferentfields: stainingmethods, animalexperimenta-
tion, clinical workandhumantherapeuticexperiments. ThisfilledEhrlich'sentireworking
time. Remarkably, he achieved his aims without any deeperinsights into the exact way in
whichsubstancesbindtocells.Thisexplainswhytherewasnodiscussionoftheside-chains
in the years after the publication ofhis habilitation thesis. In 1891 Ehrlich was still calling
himself a "clinician",38 and he had acquired his teaching licence in the field of "practical
34Paul Ehrlich, 'Modification der von Koch 36Paul Ehrlich, Das Sauerstoff-Bedarfniss des
angegebenen Methode derFirbung von Organismus. Einefarbenanalytische Studie
Tuberkelbazillen'(Deutsche Medizinische (Habilitation thesis), Berlin, Hirschwald, 1885, in
Wochenschrift, 1882), in Himmelweit (ed.), vol. 1, Himmelweit (ed.), vol. 1, op. cit., note 4 above,
op. cit., note 4 above, pp. 311-13; idem, 'Referat uber pp. 364 432, esp. p. 415. English transl. on
die gegen R. Koch's Entdeckung derTuberkelbacillen pp. 433-96.
neuerlichst hervorgetretenen Einwande' (Deutsche 37Ibid., pp. 368, 419, 422, 430 (German
Medizinische Wochenschrift, 1882), in ibid., vol. 1, original).
pp. 322-9. 38Paul Ehrlich, Zur Geschichte der Granula, repr.
35Paul Ehrlich, 'Experimentelles und Klinisches from Farbenanalytische Untersuchungen zur
uber Thallin' (Deutsche Medizinische Wochenschrift, Histologie undKlinik des Blutes, Berlin, Hirschwald,
1886), in Himmelweit (ed.), vol. 1, op. cit., note 4 1891,inHimmelweit(ed.),vol. 1,op.cit.,note4 above,
above, pp. 542-51. pp. 166-68, esp. 166.
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and clinical medicine" (praktische Medicin und drztliche Klinik).39 And in 1898, when
together with a colleague he published the results oftheir research on the blood cells, he
pointed outthe importance ofclinical examination. When describing the place oforigin of
the white blood cells, Ehrlich wrote that it would be "hard to avoid errors ifone confines
oneselfexclusively to animal experiments without supplementing these by clinical experi-
ence ... Not the anatomist, not the physiologist, but only the clinician is in a position to
discusstheseproblems".40Andfurthermore: whydidhenotapplyhisnowpublishedideaof
side-chains tothehaematological results, eventhoughthey wereconcernedwith metabolic
andmicrobiological problems, suchastheeffectofbacterialpoisonsonwhitebloodcells?41
Ehrlichwasmostlydevotedtolaboratory workbutitmadesenseforhimonlyinconnection
with practical medicine: he tried to improve diagnostic techniques and tools to make them
usable even for the untrained physician walking the wards.
These two aims mentioned by Ehrlich later as most important-chemistry as well as its
applicationtobiologicalproblemsandpracticaltherapy-couldinitiallybereachedwithout
any detailed knowledge about receptors. Moreover, private as well as professional matters
were developing. In 1883 Ehrlich married, and in 1884 his parents movedfrom Strehlen in
Upper Silesia to Berlin.42 In the very same year, Ehrlich became a titular "professor".43
(2) The Change ofEmphasis, 1889-1895
Ehrlich's situation changed rapidly afterFrerichs' death in 1885. Now he worked under
Carl Gerhardt (1833-1902), Frerichs' successor as head ofthe Second Medical Clinic of
theChariteinBerlin.Gerhardtwasmainlyinterestedinclinicalworkinthewards,notinthe
attached laboratories. He focused on the development of clinical diagnostics and on the
organizationofempirical studiesonpatients, andheintegratedEhrlichintothedailyclinical
routine. There is enough evidence that this caused Ehrlich severe trouble as he remained a
devotedlaboratory worker. He was diagnosed as tuberculous in 1888, resignedand wentto
Egypt to recover. Leaving his position in Berlin was a break in his career, particularly
becauseas,aJew,hecouldnotobtainafullprofessorshiporemploymentataStateInstitute.
Every step ofhis scientific career, which was achieved onlyby troublesome efforts, had to
be maintained if he wished to gain a respected social position.44
39Note, in Acta der Friedrich-Wilhelms-
Universitat Berlin, Habilitationen von 1880-1889,
Medizinische Fakultat-Dekanat, No.1342/1, p. 203,
Archive of the Humboldt University, Berlin.
4WEhrlich and Lazarus, op. cit., note 33 above,
p. 213.
41Ibid., p. 258.
42Baumler, op. cit., note 5 above, pp. 60, 68. See
MargaretGoldsmith's remarkonEhrlich's life afterhis
appointment to Frerichs' clinic: "The next seven or
eight years were one ofthe most fruitful and satisfying
periods ofEhrlich's life", inGoldsmith, op. cit., note 5
above, p. 71.
43Goldsmith,ibid., p.72. Theviewexpressedinthe
British Medical Journal concerning Ehrlich's work at
Frerichs' clinic, thatpractical clinical workdidnot suit
Ehrlich, is one ofthe rare comments on this topic in
the literature. See 'Obituary. Professor Paul Ehrlich',
Br.med.J., 1915,ii: 349.ForhistimewithFrerichs, see
Dolman, op. cit., note 16 above, pp. 296-7.
44Goldsmith, op. cit., note 5 above, pp. 73-4;
Dolman, op. cit., note 16 above, p. 297. For Carl
Gerhardt, see his obituary 'Professor Carl Gerhardt',
Lokal-Anzeiger, 1902, 20: No. 337, Berlin, 22 July
1902, p. 1; in Acta betr. die Anstellung des Geheimen
Medicinal Raths und Professors Dr. Gerhardt als diri-
girender Arzt und Director der 2. medicinischen
Universitats-klinik, 1885, Kgl. Charite-Direction,
No. 437, p. 37, Archive of the Humboldt-University,
Berlin.
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Ehrlich returned to Berlin in 1889.45 He was unemployed and could set up a small
laboratory only with the financial help ofhis father-in-law. He no longerhad any patients.
Now he had to rely solely on his dyes and animal experimentation. Ehrlich turned to
immunological work. The latter was not least inspired by Koch and contemporary ideas
aboutanti-bacterial treatments, andabove allby Koch'sassistantEmil vonBehring(1854-
1917) who, togetherwithhisco-workerShibasaburo Kitasato (1852-1931), discoveredthe
phenomenon of antitoxin in diphtheria and tetanus in 1890.46 Ehrlich was successful in
immunizing mice against the plant poisons, ricin and abrin; he investigated the suggested
hereditary transmission ofimmunity and its transmission viabreast feeding; he got results
on the basic processes of active and passive immunization.47
In 1890, onlyoneyearlater,theperiodofprivate scienceendedbecauseKochofferedhis
formerassistant apostasclinical supervisorforscientific studies ontuberculosis attheCity
HospitalBerlin-Moabit. NowEhrlich wasable totakeupclinicalexperimentation again, as
he had done during his time with Frerichs, and he again combined it with animal experi-
mentation and histological investigation in the laboratory. Indeed, Koch gave him a small
laboratory and afew assistants.48 Togetherwith acolleague, he explored the best tolerated
dosage of the tuberculin serum and combined therapeutic human experimentation with
histological sputum examinations.49 And he again worked with dyes in analysing the
analgesiceffectofmethylene-blue. ThesetrialswereperformedonprisonersattheImperial
Prison Moabit (K6nigliche Strafanstalt Moabit) and the associated Observation Unit for
Insane Criminals (Beobachtungsanstalt fur geisteskranke Verbrecher). The result was that
thedyemethylene-blue wasobservedtohaveaneffectoncertaintypesofpain, aboveallon
migraine.50 Methylene-blue was also tested as a therapeutic agent against malaria.5' In
1891, Koch offered him his own laboratory in the newly founded Institute for Infectious
Diseases (Institut fur Infektionskrankheiten). This was a good opportunity for Ehrlich to
start a close co-operation with the bacteriological group working under Koch, which
included Behring, Richard Pfeiffer (1858-1945), and August Wassermann (1866-1925).
Ehrlich'sinterestinimmunologygrewenormously. Aboveall,theabilityoftheorganismto
form substances (i.e. antibodies) to combat specific microbes seemed to be useful in
developing new treatments: the therapeutic sera. From 1891, therefore, Ehrlich worked
chiefly onhumanimmunology. Althoughtheinvestigationofdyes andclinical testsmoved
45Marquardt, op. cit., note 16 above, pp. 27-8;
Baumler, op. cit., note 5 above, pp. 68-9.
46Jonathan Liebenau, 'Paul Ehrlich as a commer-
cial scientist and research administrator', Med. Hist.,
1990, 34: 65-78, esp. p. 66.
47Paul Ehrlich, 'Experimentelle Untersuchungen
uber Immunitat I. Uber Ricin' (Deutsche
Medizinische Wochenschrift, 1891), in Himmelweit
(ed.), vol. 2, op. cit., note 4 above, pp. 21-6;
idem, 'Experimentelle Untersuchungen uber
Immunitat II. Uber Abrin' (Deutsche Medizinische
Wochenschrift, 1891), in ibid., pp. 27-30; idem,
'Uber Immunitat durch Vererbung und Saugung'
(Zeitschriftffir Hygiene und Infektionskrankheiten,
1892), in ibid., pp. 31-44. See, Adolf Lazarus,
Paul Ehrlich, Vienna and Berlin, Rikola, 1922,
pp. 34-5.
48Goldsmith, op. cit., note 5 above, p. 76.
49Dolman, op. cit., note 16 above, p. 297; Paul
Ehrlich, Paul Guttmann, 'Die Wirksamkeit kleiner
Tuberkulindosen gegen Lungenschwindsucht'
(Deutsche Medizinische Wochenschrift, 1891), in
Himmelweit (ed.), vol. 2, op. cit., note 4 above,
pp. 7-12.
50Paul Ehrlich and A Leppmann, 'Uber
schmerzstillende Wirkung des Methylenblau'
(Deutsche Medizinische Wochenschrift, 1890),
in Himmelweit (ed.), vol. 1, op. cit., note 4 above,
pp. 555-8.
5 Paul Ehrlich and Paul Guttmann, 'Uber die
Wirkung von Methylenblau bei Malaria' (Berliner
Klinische Wochenschrift, 1891), in Himmelweit (ed.),
vol. 3, op. cit., note 4 above, pp. 9-14.
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into the background, they continued to play a role in his daily work. Diphtheria serum, for
example, was tested on children.52
(3) Ehrlich as a Theorizer, 1895-1905
Ehrlich remained in adependentposition and his fate was again decided by his associa-
tion with Koch and by a sponsor outside the Institute. At the request of Behring, Ehrlich
turned again to investigate theoretical problems of immunity. Behring and the Hoechst
company(FarbwerkeHoechst,nearFrankfurtamMain)haddifficultieswiththeproduction
of the new therapeutic diphtheria serum. Before 1894 it was not possible to make it in
reliable concentrations. As in the case oftuberculin, the challenge was to standardize the
effective dosage. Behring asked Ehrlich forhelp and, considering the keen competition in
Koch'sInstitute, onecanassumethatitwasonly "thedirectrequestofBehring,urgedonby
an impatient Koch and a cost-conscious Hoechst Company, that would allow Ehrlich to
venture into an area to which his institute colleague had full priority claim".53 Behring
agreed with Ehrlich thatthe latter should examine the exact quantitative relations between
diphtheria toxin and antitoxin and develop a method to standardize the application ofthe
therapeutic serum.54
The research on the diphtheria serum helped to put Ehrlich's scientific career onto a
socially secure basis. In Koch's Institute, Ehrlich never got an official post because ofhis
Jewishfaith.5 Whenin 1895 the "control station" fortherapeutic sera (Controlstationflir
Heilsera) was opened in the Institute, Ehrlich became only the deputy head ofthe depart-
ment, whereas theresponsibility forits work was handed over to Koch's assistants August
Wassermann and Hermann Kossel.56 Eventually, however, the influence ofthe powerful
52See the descriptions ofthe clinical trials in Paul
Ehrlich, Hermann Kossel and August Wassermann,
'Uber Gewinnung und Verwendung des
Diphtherieheilserums' (Deutsche Medizinische
Wochenschrift, 1894), in Himmelweit (ed.), vol. 2,
op. cit., note 4 above, pp. 56-60, esp. pp. 57-60; Paul
Ehrlich and Hermann Kossel, 'Uber die Anwendung
des Diphtherieantitoxins' (ZeitschriftfiirHygiene und
Infektionskrankheiten, 1894), in ibid., pp. 61-2.
3Silverstein, op.cit., note2above,p.42.Although
Silverstein's monograph on Ehrlich's receptor
concept is almost exclusively devoted to the history of
ideas, it gives occasional hints ofthe importance of
the social setting for the development of Ehrlich's
career and the receptor concept.
54Baumler, op. cit., note 5 above, pp. 90-3.
Dolman, op.cit., note 16above,p.297. ForEhrlichand
his early involvement in the development of serum
therapy against diphtheria, see Ehrlich, Kossel and
Wassermann, op. cit., note 52 above; Ehrlich and
Kossel, op. cit., note 52 above; Paul Ehrlich and A
Wassermann, 'Uber die Gewinnung der Diphtherie-
Antitoxine aus Blutserum und Milch immunisirter
Thiere' (ZeitschriftfirHygiene und
Infektionskrankheiten, 1894), in Himmelweit (ed.),
vol. 2, op. cit., note 4 above, pp. 72-9; Paul Ehrlich,
'Uber Gewinnung, Werthbestimmung und
Verwerthung des Diphtherieheilserums' (Hygienische
Rundschau, 1894), in ibid., pp. 80-3.
55Goldsmith, op. cit., note 5 above, p. 76. In the
report onthe workofKoch's Institute of 1892, Ehrlich
is mentioned only once as a voluntary assistant. See
'Ueber den Bericht des Koch'schen Instituts fur
Infectionskrankheiten', Leipzig, Thieme, 1892 (off-
print from Deutsche Medizinische Wochenschrift, No.
4-7 (1892)), in Acta betr. die Einrichtung und die
Verwaltung des (staatlichen) Institutes fur
Infektionskrankheiten in Berlin, vom Januar 1892 bis
Dezember 1898, in GStA PK. I. HA, Rep.76
Kultusministerium, VIII B, No. 2893, pp. 63-75, esp.
p. 71. In the records of Koch's Institute, kept by the
Berlin Charit6-Hospital for the years 1893 to 1895,
Ehrlich'snamedoesnotappearatall. SeeActabetr.das
Institut fur Infectionskrankheiten, Kgl. Charite-
Direction., No. 2205, 1893-1895, Archive ofthe
Humboldt-Univerity of Berlin.
56The Prussian Minister of Science and Education
to Robert Koch, 9 Feb. 1895; Bericht uber die
Thaitigkeit des Kgl. Institutsfur Serumforschung und
Serumprufung zu Steglitz. Juni 1896-September 1899.
ZurEinweihungdesKonigl.Institutsfirexperimentelle
Therapie Frankfurt/M., Jena, Fischer, 1899, in Acta
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and well-known Ministry Councillor in the Prussian Ministry of Science and Education
(Ministerialrat impreuJ3ischen Kultusministerium), Friedrich Althoff(1839-1908), saved
Ehrlich from all the problems and difficulties ofhis provisional post. Ehrlich and Althoff
knew each other very well and also had private contacts.57 It was Althoff who promoted
Ehrlich's career further and who mainly organized the institutional framework of his
academic life. Ehrlich was grateful, as he believed his academic colleagues judged him
"unusable".58 A safe social position was a priority and had to be secured. This was so
important that Ehrlich's wife even wrote to Althoff. She was very interested in promoting
herhusband'scareer, andwas stilltryingto secure anindependentpositionforhimin 1903,
when the main decisions on Ehrlich's institutional setting had already been made.59 The
challenge ofthe diphtheria serum brought Ehrlich this independence. At the instigation of
Althoff, he became, in 1896, Head of the new Institute for Serum Research and Serum
Testing (Institut fur Serumforschung und Serumpriifung) in Steglitz in the suburbs of
Berlin.60 Its main purpose was the testing of sera, but it also enabled Ehrlich to focus
on diphtheria research in the laboratory.
TheeventsandoutcomedescribedledtoEhrlich'ssecondpredominantlytheory-oriented
phase of work, and instigated the creation of his "side-chain" and "receptor-theory".
Although relevant as an explanatory tool for his research, the "side-chains" had been
mentioned in only two of his papers between 1885 (the year of the development of his
theory) and 1897.61 In his classical study, 'The assay ofthe activity ofdiphtheria-curative
serum anditstheoretical basis' (1897),62 Ehrlich nowdefinedthe side-chains as apartofan
immunological system. He tried to find a standard dosage for the application ofdiphtheria
antitoxin. Hetestedavastnumberofdiphtheriatoxinsofdifferentoriginonguineapigsand
discovered twothresholdconcentrations. Thefirstwas acompletely neutralized solutionof
toxins, whichcausednosignsofdiseasewhenappliedtoaguineapig.Thesecondcontained
thequantityoftoxinthatkilleda250-gramanimal withinfourdays. Thedifferencebetween
betr. das Institut fur experimentelle Therapie zu
Frankfurt a.M., vom Februar 1895 bis Dezember
1900, GStA PK. I. HA, Rep.76 Kultusministerium,
Vc Sekt.l, Tit.XI, Teil H, No. 18, vol.1; pp. 1,
189-203, 203.
57For Friedrich Althoff, see Bernhard vom
Brocke (ed.), Wissenschaftsgeschichte und
Wissenschaftspolitik im Industriezeitalter. Das
"System Althoff' in historischer Perspektive,
Hildesheim, Lax, 1991; idem, 'Hochschul- und
Wissenschaftspolitik in PreuBen und im Deutschen
Kaiserreich 1882-1907: das "System Althoff"', in
Peter Baumgart (ed.), Bildungspolitik in Preufien zur
Zeit des Kaiserreichs, Stuttgart, Klett-Cotta, 1980,
pp. 9-118.
58Paul Ehrlich to Friedrich Althoff, 27 July 1907,
in Nachlass Althoff B, GstA PK. VI. HA, Rep. 92,
No. 33, pp. 217-22, esp. p. 219. See also Wolfgang
U Eckart, 'Friedrich Althoffund die Medizin', in vom
Brocke, op. cit., note 57 above, pp. 375-404, on
Ehrlich, see esp. pp. 398-401.
59See, for example, Hedwig Ehrlich to Friedrich
Althoff, 13 Sept. 1903, in Nachlass Althoff B, ibid.,
pp.71-4;Goldsmith,op.cit.,note5above,p.74.Thisis
not the place to discuss the difficulties between
Ehrlich and Behring. They are described and analysed
in the secondary literature on Ehrlich.
6 Goldsmith, op. cit., note 5 above, pp. 77-8.
61Paul Ehrlich, 'Studien in der Cocainreihe'
(Deutsche Medizinische Wochenschrift, 1890), in
Himmelweit (ed.), vol. 1, op. cit., note 4 above,
pp. 559-66; idem, 'Uber neuere Erfahrungen in der
Behandlung derTuberkulose nach Koch, insbesondere
der Lungenschwindsucht' (Transactions ofthe 7th
International Congress ofHygiene and Demography,
1891), in ibid., vol. 2, op. cit., note 4 above,
pp. 13-20.
62Ehrlich, 'Die Wertbemessung des
Diphtherieheilserums', op. cit., note 9 above, pp. 86-
106; see the English translation on pp. 107-25. The
quotations in the following footnotes refer to the
German original. For the impact of this paper on
Britain, see also H G Plimmer, 'A critical summary of
Ehrlich's recent work on toxins and antitoxins',
J. Pathol. Bacteriol., 1897, 5: 489-98.
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thefirst(neutral) andthefinal(lethal) solutionwascalledthe "singlelethaldose" (einfache
letale Dosis).63 Ehrlich's results were far from encouraging, as the concentrations of the
solutions ofthe different diphtheria toxins varied markedly. Moreover, the solutions were
not stable, but lost their toxicity after a certain period of storage, although the number of
antibody-binding unitsdidnotdecrease. Thismeantthatthetoxiceffectdidnotcorrespond
withthecapacityofthetoxintobindtoantitoxin. Theonlyexplanationforthisphenomenon
was that the toxins themselves had undergone some changes.64 Forced to explain these
results, Ehrlich came back to his "side-chain theory". The toxin was thought to consist of
two parts: a poisonous component, the so-called "toxophore group" (toxophore Gruppe),
andacomponentthatenabledthebindingtotheantitoxin,theso-called "haptophoregroup"
(haptophore Gruppe). According to Ehrlich, the toxophore group was not as stable as the
haptophore group and in consequence thetoxophore groups successively dissolved. There-
fore, to a certain extent toxins emerged which were able to bind antitoxins, but which no
longer had a toxic effect. Ehrlich called these poisons "toxoids" (Toxoide). Through that
bindingcapacity toaside-chain ofthecell, thesetoxoids wereabletoinducetheproduction
of antibodies: the latter were an overcompensated production of side-chains, which were
releasedintotheblood-stream. Thismeantthatchemicalprocesses ofspecificbinding were
combinedwithbiologicalprocessesofregeneration. Ehrlichexplainedthebindingmechan-
ismwiththeanalogythatthebiochemistEmilFischer(1852-1919)hadusedtodescribethe
effect of enzymes when he wrote about the "key-lock" mechanism.65 With his paper of
1897, Ehrlich expanded his vague and provisional idea of side-chains to a "side-chain
theory". From now on, this theory was the basis of his immunological investigations.
Ehrlich'sworkbecametheory-oriented, andimmunological studiesdominatedhisresearch
for the next few years.66
(4) From the "Side-Chains" to the Receptors
Inthefollowing years, Ehrlich's side-chain theorybecame more andmoreintricate as its
details were studied experimentally. Between 1897 and 1905, these experiments were
carried out with vast effort and extensive use of different animal species and poisonous
substances. Until 1899,thistookplaceintheSteglitzInstitut,67thereafterintheInstitutefor
Experimental Therapy (Institut fir Experimentelle Therapie) in Frankfurt am Main. The
63Ehrlich, op. cit., note 9 above, pp. 89-93.
64Ibid., pp. 93, 96. See also Lazarus, op. cit., note
47 above, p. 36.
65Ehrlich, op. cit., note 9 above, pp. 93-106
(immunological theory), p. 94 (key-lock mechanism);
Heymann, op.cit.,note9above,p. 1258.Forthehistory
ofthe "key-lock" metaphor in molecular biology, see
Friedrich Cramer, 'Emil Fischers Schlussel-SchloI-
Hypothese derEnzymwirkung-100 Jahre danach', in
Hans-Jorg Rheinberger, Michael Hagner and Bettina
Wahrig-Schmidt (eds), Raume des Wissens.
Reprasentation, Codierung, Spur, Berlin, Akademie-
Verlag, 1997, pp. 191-212. The idea of cellular
regeneration stemmed from Ehrlich's cousin Carl
Weigert and was developed in contact with the
latter, see Heymann, ibid. For the toxin-antitoxin
reaction and Ehrlich's work, see Pauline M H
Mazumdar, 'The antigen-antibody reaction and the
physics and chemistry oflife', Bull. Hist. Med.,
1974, 48: 1-21.
66ForthisperiodofEhrlich'swork, seeDolman,op.
cit., note 16 above, p. 298.
67For the work done in the Institut fur
Serumforschung und Serumprufung in Steglitz,
see Wilhelm D6nitz, 'Bericht uber die
Thatigkeit des Konigl. Instituts fur Serumforschung
und Serumprufung zu Steglitz, Juni 1896-
September 1899', Klin. Jahrb., 1899, 7: 359-84.
Donitz remarked that the biological application
of the chemical theory of the side-chains would
be the basic idea of all research acitivities of the
Institute.
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latter was set up for Ehrlich by the Prussian State, again with the support of Althoff.68
Ehrlich was able to organize and to co-ordinate experimental studies, andhe pushed many
assistants to work hard on their subjects. His right-hand man and coordinator for the
laboratory investigations onthe side-chain theory was thebacteriologistJuliusMorgenroth
(1871-1924), who had been Ehrlich's assistant in Steglitz since 1897.69 But Ehrlich
continued to be the spiritus rector of the whole project, and he urged his assistants to
perform more and more animal experiments toconsolidate his theory. Ehrlich's laboratory
notes show this, as for instance when he demanded: "Please also show me the Pyrodin-
animals", or simply "Where is the ape?"70 Accordingly, the "side-chain theory" devel-
oped. The "toxoids", those poisons capable of cell-binding, were supplemented by the
"toxons" (Toxone) only a year later, in 1898.71 The toxons were also ineffective poisons,
but, incontrast to thetoxoids, they were synthesized andreleasedby the microbe itselfand
had not lost their toxophore group.
Besides analysingpoisons,Ehrlichconcentratedonthemechanisms andprocessesofthe
side-chain theory itself. The animal experiments on haemolysis, i.e. the solvent action of
antibodies on red blood corpuscles, seemed to be helpful. This could be compared with
antibodies attacking bacilli. Some studies on haemolysis, published together with
Morgenroth, enabled Ehrlich to improve the side-chain theory decisively. The so-called
"addiment" (Addiment), was responsible forthe dissolution ofthe red blood cells through
bindingtoanantibodyor"immune-body" (Immunkorper),enablingthisantibodytobindto
red blood cells and to dissolve them. Consequently, Ehrlich assumed that there were not
only antibodies withonebinding groupbut also antibodies with twobinding groups. These
were able to bind the "addiment" as well as the red blood cell. Now Ehrlich compared
haemolysis with the physiological process of nutrition. This increased the impact of his
theory. The addiment couldbe compared with adigestive ferment. Adouble-binding side-
chain attached to the surface of a cell could bind both a digestive ferment and "giant
molecules" (Riesenmolekiile), i.e. unprepared nutritive substances. These giant molecules
could be prepared for cellular digestion by the digestive ferment.72 In this way, Ehrlich
openedupthepathfromthemoreorlessnarrowimmunologicalterraintotheunderstanding
of the general metabolism of the human organism.
The side-chain theory appeared to be a good explanatory model to uncover the deepest
secrets of biological chemistry. In 1899, Ehrlich postulated a countless number of side-
chains, which would adapt to the "constantly changing chemistry" of the body. This
chemistry would be influenced by race, sex, nutrition, energy, secretion and otherfactors,
andsotherewasacontinuouschangetakingplaceinthebloodserum.Furthermore,notonly
inthecase ofhaemolysisbutalsoinregularconditions, thebloodcontainedimmunebodies
68Goldsmith, op. cit., note 5 above, p. 78. 71Paul Ehrlich, 'Uber die Constitution des
69For the life ofMorgenroth, see Baumler, op. cit., Diththeriegiftes' (Deutsche Medizinische
note 5 above, p. 329; D6nitz, op. cit., note 67 above, Wochenschrift, 1898), in Himmelweit (ed.), vol. 2,
p. 360. op. cit., note 4 above, pp. 126-33.
70"Bitte mir auch die pyrodin-thiere zeigen!", 72Paul Ehrlich and Julius Morgenroth, 'Zur
"Wo bleibt der Affe !", see Note, 6 March 1900, Theorie der Lysinwirkung' (Berliner Klinische
p.13; Note, 1900 (no day and month), p. 30, in Zettel Wochenschrift, 1899), in Himmelweit (ed.), vol. 2, op.
Buch I, I Feb. 1900, to 26 Dec. 1900, box 7, series II, cit., note 4 above, pp. 143-9. English transl.
(3)-i, 2, 4, Paul Ehrlich Collection, RUA, RAC. pp. 150-5.
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withtwobinding sites. Ehrlichcalledthem "interbodies" (Zwischenkorper). Normalblood
also contained addiment, which Ehrlich called "complement" (Komplement).73
Finally, in 1900, Ehrlich and his colleague Morgenroth, in their third paper on haemo-
lysins,introducedtheterm "receptor": "Forthesakeofbrevity,thatcombininggroupofthe
protoplasmic molecule to which the introduced group is anchored will hereafterbe termed
receptor."74 The side-chainsassuchhadplayedaminorroleinEhrlich'sresearchuntilthis
pointinhiscareer. Hehadconcentrated mainly ontherelations between poison, addiment,
ferment and complement, less on the character ofthe side-chain as such. The titles ofthe
published papers illustrate this. Even the third paper on haemolysins is chiefly about the
classificationofthedifferentkindsofcomplement.75 Thefourthreportonhaemolysinsalso
dealsmainlywithcomplement. EhrlichandMorgenrothclaimedthatthereweremanytypes
and the constitution of the complement became also more intricate.76
The introduction ofthe term "receptor" was notmerely anewtermforan "oldidea".77
Afterhaving sortedoutthemeaningofthe "side-chains" withthecreation ofa "side-chain
theory", investigation ofthe nature ofside-chains was inevitable. The new heading stands
forthecentralpositionoftheside-chains inEhrlich'snewresearch strand. The "receptors"
andtheirspecificityforcertainpoisons soon stoodinthecentreofEhrlich'simmunological
theory.78 In 1901, Ehrlich and Morgenroth, when deepening their research on the general
topic, made someremarksonthe "peculiarities ofthereceptorapparatus". Theystatedthat
there would be a vast number of receptors attached to the red blood cells and that these
receptors could bind to diverse immune bodies and haemotoxins.79 As in the case of the
antibodies orintermediatebodies,the structureofthereceptorswasanalysedandclassified.
As complex receptors with two haptophore groups, the intermediate bodies (antibodies
regularly belonging to the immune system) were now called "amboceptors" (Ambocep-
toren).80This view ofreceptors saw them asflexible entities, firstofall attached tothecell
and binding toxins orimmune bodies, but then also doing the same in the blood-stream.8'
ButEhrlichconceded soonthatthere werereceptorswhich, eveninthecaseofasuccessive
... standigwechselndenChemismus", seePaul
Ehrlich and Julius Morgenroth, 'Uber Hamolysine.
Zweite Mittheilung' (Berliner Klinische
Wochenschrift, 1899), in Himmelweit (ed.), vol. 2,
op. cit., note 4 above, pp. 156-64, esp. p. 162. English
transl. pp. 165-72, esp. p. 170.
74"Wir wollen im Folgenden stets, um eine gros-
sere Kiirze des Ausdrucks zu ermoglichen, diejenige
bindende Gruppe im Protoplasmamolekiil, an welche
eine fremde, neu eingefuhrte Gruppe angreift, allge-
mein als 'Receptor' bezeichnen". SeePaulEhrlichand
Julius Morgenroth, 'Uber Hamolysine. Dritte
Mittheilung' (BerlinerKlinische Wochenschrift, 1900),
in Himmelweit (ed.), vol. 2., op. cit., note 4 above,
pp. 196-204, esp.p. 196.Englishtransl. pp.205-12,the
quotation is on p. 205.
75Ibid.
76Paul Ehrlich and Julius Morgenroth, 'Uber
Hamolysine. Vierte Mittheilung' (Berliner Klinische
Wochenschrift, 1900), in Himmelweit (ed.), vol. 2,
op. cit., note 4 above, pp. 213-23. English transl.
pp. 224-33.
77See the quotation in Silverstein, op. cit., note 2
above, p. 80. The introduction ofthe term "receptor"
in 1900isunderestimatedbySilverstein, whodescribes
it merely as a "reminder that the side-chain theory
holds that antibodies are cell receptors", p. 105.
78E Freiherr von Dungern, 'Rezeptorenspezifitat',
in Apolant, et al., op. cit., note 19 above, pp. 162-5.
79"Eigenthumlichkeiten des Receptoren-
apparates", see Paul Ehrlich and Julius Morgenroth,
'Uber Hamolysine. Funfte Mittheilung' (Berliner
Klinische Wochenschrift, 1901), in Himmelweit (ed.),
vol. 2, op. cit., note 4 above, pp. 234-45, esp.
p. 238. English transl. pp. 246-55, esp. p. 249.
80Ibid., p. 244, German original. Paul Ehrlich and
Julius Morgenroth, 'Uber Himolysine. Sechste
Mittheilung' (BerlinerKlinische Wochenschrift, 1901),
in Himmelweit (ed.), vol. 2, op. cit., note 4 above,
pp. 256-77, esp. p. 272. English transl. pp.
278-97.
81Lazarus, op. cit., note 47 above, pp. 41-2.
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overproduction of the cell, would not be released into the blood-stream. Instead they
remained at the surface ofthe cell. Ehrlich called them "sessile receptors" (sessile Recep-
toren).82 But they remained as only one subspecies. Some receptors were common to
different animal species and could be found in many organs. A receptor could have
many complement binding groups, so mutating to a "triceptor" (Triceptor) or "quadri-
ceptor" (Quadriceptor).83 The step to postulate the existence ofthe "polyceptor" (Poly-
ceptor), able tobind many complements, was eventually taken in 1905.84 One yearbefore,
in 1904, Ehrlich had divided the receptors according to their ability to bind substances,
distinguishing receptors of first, second and third order.85 All those with two or more
binding sites belonged to the receptors of third order. The blood plasma was filled with
a vast number of receptors, which Ehrlich called "haptines" (Haptine). These haptines
covered all those substances which at the time were not yet identified.86 Finally, he
approached what he called the "pluralistic point of view" (plurimistischer Standpunkt).
This was the assumption of a whole range of different complements, anti-complements,
receptors, andmanyothersubstances.87 Becausetheyplayedakeyroleinimmunology and
incombatingmicrobes,88 aswell asinthephysiology ofnutritionandhumanmetabolismin
general, Ehrlich predicted a great impact ofthe receptorconcept on clinical medicine, and
he assumed that his studies on receptors would "open a new meaningful direction of
biological research".89
(5) The Fightfor the Receptors and Lost Alternatives
Ehrlich's experimental methods were refined again and again, for example with the
application of new chemicals. He got confirmation and support from colleagues, but
he could not provide direct evidence for his theory as the receptors were not visible.90
The experimental setting and his exact methods enabled Ehrlich to identify the microcos-
mosofsubstancesonlyindirectly, fromreactionsoftheblood sera. Heknewthathistheory
forthepresentremained only atheory. Butbecause itwasbasedonexperimentalevidence,
he thought it legitimate to publish theresults.91 In 1901, he maintained that the side-chain
82Ehrlich and Morgenroth, 'UberHamolysine.
Sechste Mittheilung', op. cit., note 80 above, pp. 256,
258.
83Ibid., pp. 268, 273.
84Paul Ehrlich and Hans Sachs, 'Uber den
Mechanismus der Antiamboceptorwirkung' (Berliner
Klinische Wochenschrift, 1905), in Himmelweit (ed.),
vol. 2, op. cit., note 4 above, pp. 432-41, esp. p. 434.
85Paul Ehrlich, 'Uber den Receptorenapparat der
rothen Blutkorperchen', from Paul Ehrlich (ed.),
GesammelteArbeitenzurImmunitatsforschung, Berlin,
Hirschwald, 1904, in Himmelweit (ed.), vol. 2, op. cit.,
note 4 above, p. 316-23, esp. p. 317.
86Paul Ehrlich, 'Die Schutzstoffe des Blutes'
(Verhandlungen der73. VersammlungderGesellschaft
derNaturforscher undArzte, 1901), in Himmelweit
(ed.), vol. 2, op. cit., note 4 above, p. 298-315, esp.
p. 312.
87Ibid., p. 313.
88Ehrlich decided to apply a specific bacterial
serum to different animal species with a different
receptor apparatus. Thus he aimed to produce antibo-
dies against all bacterial receptors ofthis microbe. He
thoughtthis apossible wayofmapping allreceptors of
this microbe. It could then be combatted effectively
with atherapeutic serum produced fromthe mixture of
the produced antibodies. See Ehrlich and Morgenroth,
'Uber Hamolysine. Sechste Mittheilung', op. cit., note
80 above, p. 259.
89 eine neue bedeutungsvolle Richtung der
biologischenForschungeroffnet". SeeEhrlich,op.cit.,
note 85 above, p. 320. See also Dolman, op. cit., note
16 above, pp. 298-9.
90D6nitz, op. cit., note 67 above, pp. 376-84.
91Paul Ehrlich, 'Toxin und Antitoxin. Entgegnung
auf den neuesten Angriff Grubers' (Miinchener
Medizinische Wochenschrift, 1903), in Himmelweit
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theoryhad "passedthetestperfectly".92Theappearanceofscientificphenomenathatwere
inconsistent with his theory were explained by Ehrlich as a result of the highly intricate
conditions ofthe animal organism. The inconsistencies would serve to deepen the theory
and topromote its success.93 Thus atheory shouldnotbe dismissed as soon as any contra-
diction occurred, but should be carefully rethought. Ehrlich saw himself as a pioneer of
a new medicine of the future, and he compared his "side-chain theory" with Rudolf
Virchow's(1821-1902) "cellularpathology",whichalsohadnotbeensuccessfulatonce.94
The insecure basis of Ehrlich's theory provoked critics even at an early stage in its
development. The critics and his way of dealing with them led Ehrlich deeper into his
receptor concept. He attributed what he called the "unitarian view" (unitarischer Stand-
punkt) to many ofhis critics. This attitude stood in sharp contrast to his own "pluralistic
conception" (plurimistischeAnschauung). Basedontheirown experiments, theunitarians
attacked specific points ofthe side-chain theory and thereby questioned Ehrlich's micro-
cosmos ofimmunological substances.95 Ehrlichidentifiedoneopposinggroupofscientists
at the Pasteur Institute in Paris: the French immunologist and bacteriologist Emile Roux
(1853-1933), madedeputydirectorin 1895 andsince 1904directorofthePasteurInstitute,
his Belgian colleague and co-worker Jules Bordet (1870-1961), and the Russian immu-
nologist and bacteriologist Elie Metchnikoff (1845-1916), who had worked at the
Institute since 1888. The dispute between these three researchers on one side and Ehrlich
on the other began about 1897, and went on for about ten years.96 The most important
conflict was, however, with Jules Bordet. The latterhaddeveloped a special theory on the
dissolutionofredbloodcells. In 1900,Bordetdeclaredtheretobenodirectrelationbetween
immune bodies and complement. The red blood cells were merely made sensitive by the
immunebodies-aviewrejectedbyEhrlichaspurelymechanistic. Followingthat,thecells
wereinfluencedbythecomplement, whichBordetnamed "alexine" (Alexin). Furthermore,
Bordet questioned the existence of a variety of immune bodies on the basis of his own
experiments on haemolysis. In one species there was only one alexine, causing both
haemolysis and bacteriolysis.97
Such attacks annoyedEhrlichconsiderably, andtheexample ofthe Paris trio reveals his
methods ofdealing with critics ofthe side-chain theory. Ehrlich instructed his assistants to
(ed.), vol. 2, op. cit., note 4 above, pp. 368-90,
esp. p. 383.
92" die Probe des Versuchs aufs Beste bestan-
den". See Ehrlich, op. cit., note 86 above, p. 306.
93Ehrlich and Morgenroth, 'Ober Hamolysine.
FunfteMittheilung', op. cit., note79above, pp. 234-5.
94Paul Ehrlich to Veit (this could have been
either Gustav Veit or Johann Veit), 22 Jan. 1903, in
Direktor, EhrlichX, 23 Dec. 1902to26Jan. 1903, box
22, series V, (3-complete)-1, 2, 4 (2-incomplete),
pp. 169-71, esp. 171, Paul Ehrlich Collection,
RUA, RAC.
95Ehrlich and Morgenroth, 'Ober Hamolysine.
SechsteMittheilung',op.cit., note80above,pp.256-7,
English transl. pp. 278-9.
96See Ehrlich's remark about Roux and Buchner
which seems tohave started thedispute aboutthe side-
chain theory, Paul Ehrlich, 'Zur Kenntnis der
Antitoxinwirkung' (Fortschritte derMedizin, 1897), in
Himmelweit (ed.), vol. 2, op. cit., note 4 above,
pp. 84-5.
97Ehrlich and Morgenroth, 'Uber Hamolysine.
Vierte Mittheilung', op. cit., note 76 above, pp. 214,
218, 220-3. For Bordet, see Jules Bordet, 'Le
Mecanism de l'agglutination', Annales de L'Institut
Pasteur, 1899, 13: 225-50; idem, 'Agglutination et
dissolution des globules rouges par le serum',Annales
de L'InstitutPasteur, 1899, 13: 273-97; idem, 'Les
serums hemolytiques, leurs antitoxines et les theories
des serums cytolytiques', Annales de L'Institut
Pasteur, 1900, 14: 257-96. See also Aschoff, op. cit.,
note 9 above, pp. 96-8; Silverstein, op. cit., note 9
above, pp. 99-104, and the detailed analysis ofEileen
CristandAlfredITauber, 'Debatinghumoralimmunity
and epistemology: the rivalry of the immunochemists
Jules Bordet andPaulEhrlich',J. Hist.Biol., 1997, 30:
321-56, esp. p. 329.
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repeat Bordet's experiments, and under the heading "against Bordet" (gegen Bordet) he
gavedirectionsonpiecesofpaper.Theresultsoftheexperimentsdidnotleadtoarevisionof
the side-chaintheory,buttoitsvindication. Thenewlyobtainedimmunological knowledge
wasintegratedintoEhrlich's flexible, pluralistic theory.98 Inthis senseallthecontributions
ofEhrlich and his workers served not only to consolidate the side-chain theory but also to
defend itagainst any objections. Ehrlich had abusy correspondence withcolleagues. Inhis
letters, he reported promptly on his latest findings and dissected the experiments of his
opponents, describing them as failed criticism of the side-chain theory. For example,
EhrlichreportedtoacolleaguethatMetchnikoffwasthe "realspiritusrector" oftheattacks
from Paris, having softsoaped Roux with his "breathtaking personality". It was "such a
shamethatsuchanexperimenterandsuchaclearheadasRouxgotsodeeplyintomysticism
and into the Russian fog".99 Ehrlich was friends with many ofhis opponents, but when it
cametohistheory,heunfoldedamassivecampaignagainstanycritics, infrontorbehindthe
curtain. Ehrlich complained about seemingly disparaging remarks in secondary literature.
OncehetriedtourgetheeditorofthejournalDeutscheMedizinische Wochenschriftto stop
theprintingofcriticalremarksbyoneofhisopponents, becausehisowntheory "hadgained
full acceptance already".10 Ehrlich sorted his colleagues into friends and enemies ofhis
theory. In October 1902, he wrote to William Henry Welch (1850-1934): "I was most
delighted to recognize you as one ofthe warmest friends ofthe theory, but even more that
youcouldachievesuchnewandfundamentalinsightswithitshelp". Incontrast,hewroteto
apharmacologist inHalle, Germany, "thateveryimpartialpersonreadingtheliteraturehas
tocountyouasanabsoluteopponent".'01 Again,Ehrlichrelatedtheremarkto "thetheory",
whichoccupiedhimmore andmoreinthe years after 1897. Thisbecomes apparentthrough
other critics of his concept.
98TwoLaborzettel,both 1901,inZettelBuchIIund
Carcinom, 25 Dec. 1900 to21 Sept. 1901,box 8, series
II, (3)-i, 2, 4, pp. 292, 293, Paul Ehrlich Collection,
RUA, RAC. For some general remarks on the dispute
between Ehrlich and Bordet, see also Arthur M
Silverstein, 'Pasteur, Pastorians, and the dawn of
immunology: the importance ofspecificity', Hist.
Philos. Life Sci., 2000, 22: 29-41, esp. pp. 37-9; and
the comments ofAugust von Wassermann, op. cit.,
note 19 above, pp. 148-50.
99"... der 'wirkliche spiritus rector'; mit seiner
'hinreissenden pers6nlichkeit'. Es sei 'jammerschade,
dass ein solcher experimentator und klarer kopf wie
Roux so in den mysticismus und den russischen
nebel gerathen musste!"'. See Paul Ehrlich to Carl
Salomonsen, Copenhagen, 24Feb. 1899, inCopirBuch
Im. Ehrlich, 21 Feb. 1899 to 31 July 1899, box 5, series
I, (3)-1, 2,4, pp. 13-16, PaulEhrlichCollection, RUA,
RAC.Metchnikoff'stheoryofphagocytosis(digestion)
ofbacilli through leucocytes and the latter's ability to
produce antitoxin was seen as an attack on the "side-
chain theory" by Ehrlich; see Aschoff, op. cit., note
9 above, pp. 28, 42-3, 103-4, 115-17. For some
general remarks on the dispute between Ehrlich and
Metchnikoff, seeSilverstein, op.cit., note98above,pp.
35-7; Oswin Gunther, 'Immunitatstheorien. Von der
Seitenkettentheorie zurFlieBbandtheorie', inZum 100.
Geburtstage PaulEhrlichs undzum Wiederaufbau des
Paul-Ehrlich-Instituts,ArbeitenausdemPaul-Ehrlich-
Institut, dem Georg-Speyer-Haus unddemFerdinand-
Blum-Institut zu Frankfurt a. M., Issue 51, Stuttgart,
Gustav Fischer, 1954, pp. 68-107, esp. pp. 75-81.
100, .-. in der ganzen Linie sich anerkennung
verschafft haben". See Paul Ehrlich to RudolfKobert,
Rostock, 1 Dec. 1902; Paul Ehrlich to Albert
Eulenburg, Berlin, 15 Nov. 1902, in Direktor, Ehrlich
IX, 25 Sept. 1902 to 23 Dec. 1902, box 21, series V,
(3-complete)-l, 2, 4 (2-incomplete), pp. 434-47,
esp. 434-7; pp. 376-7, quotation on p. 377, Paul
Ehrlich Collection, RUA, RAC.
101 "Hocherfreulich waresmir,Siewiederalseinen
so warmen freund der theorie zu erkennen, noch mehr
aber, dass Sie durch diesselbe zu so neuen und fun-
damentalen gesichtspunkten gekommen sind"; "dass
jeder Unbefangene, der die Literatur liest, Sie zu den
absoluten Gegnern zihlen muss."; See Paul
Ehrlich to William H Welch, Baltimore, 20 Oct.
1902; Paul Ehrlich to Ernst Fuld, Halle, 27 Oct. 1902,
in Direktor, Ehrlich IX, ibid., pp. 117-18, 182-7, esp.
pp. 182-3.
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Ehrlich's style of dealing with critics of the side-chain theory can also be found in his
controversy with the physical chemist Svante Arrhenius (1859-1927) and his student
Thorvald Madsen (1870-1957), which startedin 1903. Ehrlichhadtodefendhisbiological
point ofview against a physico-chemical interpretation ofantitoxin-toxin binding. Arrhe-
nius and Madsen applied basic chemical laws to processes of life, which, according to
Ehrlich, could not be expressed in such rigid formulas. Above all, Arrhenius adopted
Bordet'sunitarianpointofviewonthecomplementandthehaemolysisofblood.102Ehrlich
again carriedoutexperiments and started alettercampaign againstArrhenius.103 In aletter
to Althoff, presumably written in 1904, Ehrlich notedthat Arrhenius would be "pushed to
the wall".104
EvenmoreseriouswasEhrlich'sdisputewithMaxvonGruber(1853-1927),professorof
hygiene at Vienna from 1887 to 1902 and at Munich from 1902 to 1923. Although giving
himcreditfornewfindingsinthefieldofimmunology,GruberattackedEhrlich'spluralism
ofspecifictoxines andimmunebodiesinaverypolemical way, aspurelyspeculativewitha
nearly total lack of evidence. He did this in several papers on immunology, published
between 1901 and 1903. Again,Ehrlichmadetremendouseffortstoexplaintohisacademic
friends theweakness ofGruber's criticism. Ehrlich and somecolleagues were even evicted
from a train, because the former had complained loudly about the rhetoric ofGruber.105
Ehrlich rejected the hygienists' criticism entirely as "stupid" (blodsinnig) and treated it
as a "quantitene'gligeable". This again led Gruber to point out "thathe solely reproaches
him [Ehrlich] for in the course of his theorizing permitting too much fantasy and too
little criticism".106Beyond any judgement on the comments of the "gifted polemicist"
102PaulEhrlichtoSvanteArrhenius, 1 Jan. 1903, in
Direktor, Ehrlich X, 1902,23 Dec. to26Jan. 1903, box
22, series V, (3-complete)--, 2, 4 (2-incomplete),
pp. 71-9, Paul Ehrlich Collection, RUA, RAC. Svante
Arrhenius and Thorvald Madsen, 'Anwendung der
physikalischenChemieaufdasStudiumderToxineund
Antitoxine', Zeitschriftffir Physikalische Chemie,
1903,44: 7-62; SvanteArrhenius,Quantitative lawsin
biological chemistry, London, G Bell, 1915, esp.
pp. 110-39. For a detailed description of the Ehrlich-
Arrhenius controversy, see Lewis P Rubin, 'Styles in
scientific explanation: Paul Ehrlich and Svante
Arrhenius on immunochemistry', J. Hist. Med. Allied
Sci., 1980, 35: 397-425.
103For example, Paul Ehrlich to Paul Heinrich
Romer, 8 July 1903, in Direktor, Ehrlich XI, 1903, 13
Mar. to 17July 1903, box23, seriesV, pp.445-8; Paul
Ehrlich to S J Meltzer, 30 Dec. 1903, in Direktor,
Ehrlich XIII, 21 Dec. 1903 to 13 June 1904, box 23,
seriesV,pp.44 6,PaulEhrlichCollection,RUA,RAC.
See also further letters of Ehrlich in this file.
104Paul Ehrlich to Friedrich Althoff, 12 Sept.
presumably 1904, in Nachlass Althoff A I, GStA PK.
VI.HA,Rep.92,No.258,pp.15-16,esp.pp.22-30.For
the controversy between Ehrlich and Arrhenius/
Madsen, see also Pauline M H Mazumdar, Speciesand
specificity: an interpretation ofthe history of
immunology, Cambridge University Press, 1995,
pp. 202-13.
105Claude E Dolman, 'Paul Ehrlich and William
Bulloch: a correspondence and friendship (1896-
1914)', Clio Medica, 1968, 3: 65-84, esp. pp. 80-1;
Max Gruber, 'ZurTheorie derAntikorper. I. Ueberdie
Antitoxin-Immunitat', Munchener Medizinische
Wochenschrift, 1901,48: 1827-30, 1880-4; idem, 'Zur
Theorie der Antikorper. I. Ueber Bakteriolyse und
Haemolyse', ibid., pp. 1924-7, 1965-8; idem, Cl.
Freiherr v. Pirquet (Referent: M. Gruber), 'Toxin und
Antitoxin', Munchener Medizinische Wochenschrift,
1903, 50: 1193-6, esp. p. 1194; Max Gruber, 'Toxin
undAntitoxin.BemerkungenzuEhrlichs "Entgegnung
auf Grubers Replik"', Miunchener Medizinische
Wochenschrift, 1903, 50: 2297; idem, 'Neue Friichte
der Ehrlichschen Toxinlehre', Wiener Klinische
Wochenschrift, 1903, 16: 791-3.
106Paul Ehrlich to Paul Heinrich Romer, 8 July
1903, in Direktor, Ehrlich XI, 13 Mar. 1903 to 17 July
1903, box 23, series V, pp. 445-8, Paul Ehrlich
Collection, RUA, RAC: "... ich mache ihm nur zum
Vorwurf, dass er bei seinem Theoretisieren zuviel
Phantasie und zu wenig Kritik walten lasse". See
Max Gruber, 'Toxin und Antitoxin. Eine Replik
aufHerrn Ehrlichs Entgegnung', Munchener
Medizinische Wochenschrift, 1903, 50: 1825-8,
esp. p. 1825.
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Gruber,107 it is evident that he hit Ehrlich on a vulnerable spot. All the inventions ofnew
termsandsubstancescouldnotreallyexplaintheformationofantibodies. Grubermadeone
generalremarkwhichexplainshisattitudebest: "Onlytheconditionswhichaccompanythe
processes oflife are accessible to ourresearch".108 Ehrlich, despite his adverse reaction to
Gruber's remarks, published two papers devoted to his opponent in 1903.109
ThestrongestblowagainstEhrlich'sside-chainandreceptortheorycamefromagroupof
immunochemists, who attacked the chemical specificity of the concept on unitarian
grounds. The most important of these was the Viennese pathologist and immunologist
Karl Landsteiner (1868-1943). As a student ofGruber in 1896, he became involved in the
dispute with Ehrlich and joined the front-line of Ehrlich's opponents. Landsteiner then
developed the colloid theory of immunology: reactions are influenced by the chemical
constitution of substances, but above all the quantitative relationship is influenced by
physicalphenomena such as solubility andtemperature. EchoingGruber'scriticism, Land-
steiner attacked Ehrlich's "uneconomical" pluralism, which in his view was loaded with
too manyuncertainties. From 1903 onwards, Landsteinerinvadedthe fieldofimmunology
with histheory.!10 By 1912 "the colloid theory had superseded Ehrlich's, although in the
practice ofthe serum institutes the old assumption ofclear-cut, one-to-one specificity was
essentially unchanged"!ll
AllthesecriticsdidnotleadEhrlichtorethinkhispluralistic attitudes. Onthecontrary, as
many printed and unprinted sources show, he became more and more obsessed with his
theory inthefirstyears after 1900. Ehrlich alwayshadonly ameagre interestinculture and
politics, andthere are no hints thatherecognized his involvement in the state-oriented and
nationalistic bacteriological research of his teacher Koch.'12 Ehrlich talked incessantly
about his work, painted sketches ofthe receptors on note-pads, letters, postcards and even
on the floorortablecloths.'13 And, as weknow from the recentcontribution ofCambrosio,
Jacobi andKeating, theimagesthemselvesfuelledthecriticismoftheiropponentsthatthey
were an attempt by Ehrlich to illustrate invisible structures, whose material existence was
notevidentbutdebated atthis time. BordetmadeEhrlich'sgraphic representations respon-
sible for the success ofthe side-chain theory, arguing that it was not based on fact but on
107Michael Hubenstorf described Gruber as a
"gifted polemicist" (begabter Polemiker), see idem,
'Gruber, Max (von)', in Wolfgang U Eckart and
Christoph Gradmann (eds), Arzte Lexikon. Von der
Antike bis zur Gegenwart, 2nd ed., Berlin and
Heidelberg, Springer, 2001, pp. 140-1, esp. 140.
'08"Nur die begleitenden Umstande der
Lebensvorgange sind unserer Forschung zuganglich."
See Gruber, op. cit., note 106 above, p. 1827.
109Ehrlich,op.cit.,note91 above;idem, 'Toxinund
Antitoxin. Entgegnungen auf Grubers Replik'
(Minchener Medizinische Wochenschrift, 1903), in
Himmelweit(ed.),vol.2,op.cit.,note4above,pp.391-
94. Forthedebatewith Gruber, seeSilverstein, op. cit.,
note 9 above, pp.104-7. For the controversy between
Ehrlich and Gruber, see Mazumdar, op. cit., note 104
above, pp. 123-35.
l"OSee the detailed analysis in Mazumdar, op. cit.,
note 104above,pp. 107-278,esp.pp. 136,216-17,147,
226.
"'Ibid., p. 255.
"2See Paul Weindling, 'Scientific elites and
laboratoryorganisationinfindesiecleParisandBerlin:
the Pasteur Institute and Robert Koch's Institue
for Infectious Diseases compared', in Andrew
Cunninghamand PerryWilliams (eds), The laboratory
revolution in medicine, Cambridge University Press,
1992, pp. 170-88; Christoph Gradmann, 'Money and
microbes: Robert Koch, tuberculin and the foundation
of the Institute for Infectious Diseases in Berlin in
1891', Hist. Philos. Life Sci., 2000, 22: 59-79; Heinz-
Peter Schmiedebach, 'The Prussian state and micro-
biological research-Friedrich Loeffler and his
approach to the "invisible" virus', Arch. Virol., 1999,
15: Suppl., pp. 9-23; Ragnhild Munch and Stefan S
Biel, 'Expedition, Experiment und Expertise im
Spiegel des Nachlasses von Robert Koch', Sudhoffs
Archiv, 1998, 82: 1-29.
13Marquardt, op. cit., note 17 above, pp. 29, 36,
40-2, 54-5.
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image, which was thenwrongly accepted asthepicture ofreal material life.114Remarkably
enough, Ehrlich's efforts to consolidate the receptortheory were supportedby the realm of
literary fiction. One ofthe few things Ehrlich did in his leisure hours was to read detective
stories, especially thoseofSirArthurConan Doyle (1859-1930). These servedto stimulate
reflection on his work, forhe filled the margins with comments andformulas.'15 The ideas
ofhisteacherRobertKochfloodedbackinhismindthroughliterature: ConanDoylewasan
admirer of Koch and did not hesitate to travel to Berlin in 1890 to investigate the bacter-
iologist'stuberculincure. Doyle'sfascinationwiththeideaofpreventingtheinvasionofthe
empire by microbes shaped the work of his fictional hero Sherlock Holmes. The latter
concentrated explicitly on detecting the "invisible" and subversive threads oflife. Doyle
saw both Holmes and Koch as "imperial knights" who saved their empires."6
The experimental facts and the production of sketches of the actually invisible immu-
nologicalentitiesconflatedinEhrlich's work.1'7Togetherbothhadtoensurethecredibility
of the side-chain and receptor theory just as visual (early photography) and functional
(animal experimentation) proof had to demonstrate evidence for Koch's postulation of
living microbes."8 Ehrlich explained that his sketches would be "merely a pictorial
method" andtherefore thattheydidnotcorrespondtoreality. 119 But such singularremarks
fadebeforetheextensiveuseEhrlichmadeofhispictures topersuadehiscontemporaries of
the truthfulness of his theory. The images, as well as their conflation with experimental
evidence, were in turn boosted by the criticism of them. The system allowed Ehrlich to
reconstruct and enlarge his receptor concept infinitely as there was no factual resistance.
Therefore,notwithstanding theopposingviews, Ehrlichcomparedhimselfwithavictorious
chessplayerwhocannotfinishthegamebecausehisdefeatedopponents donotwanttogive
up.'20 The intense concentration on the side-chains and the receptors decreased only
gradually until 1905, in parallel with the increase of his cancer research and finally-
from about 1906-with his work on chemotherapy. The impact of Landsteiner's immu-
nological theory on Ehrlich's shift of interests is questionable: in 1906, Ehrlich was still
criticizing colloidchemistry.'2' Hethoughthisowntheorycompleteandhenowuseditas a
tool to examine other fields of medical research.'22
114Alberto Cambrosio, Daniel Jacobi, and Peter
Keating, 'Ehrlich's "beautiful pictures" and the con-
troversial beginnings ofimmunological imagery', Isis,
1993, 84: 662-99, esp. pp. 667-9, 684; Crist and
Tauber, op. cit., note 97 above, pp. 336-7; 346-53.
"15Marquardt, op. cit., note 17 above, pp. 28-9;
Dolman, op. cit., note 105 above, p. 81.
116For Doyle's work and its interpretation see the
brilliant analysis ofLaura Otis, 'Arthur Conan Doyle:
an imperial immune system', in idem, Membranes:
metaphorsofinvasion in nineteenth-century literature,
science, andpolitics, Baltimore and London, Johns
Hopkins University Press, (1999) 2000, pp. 90-118,
esp. pp. 91-8.
117Cambrosio, Jacobi, and Keating, op. cit., note
114 above, p. 699.
118Thomas Schlich, 'Linking cause and disease
in the laboratory: Robert Koch's method of super-
imposing visual and "Functional" representations
of bacteria', Hist. Philos. Life Sci., 2000, 22:
43-58.
"9Paul Ehrlich, 'On immunity with special refer-
ence to cell life: Croonian Lecture (Proc. Roy. Soc.
1900), in Himmelweit (ed.), vol. 2, op. cit., note 4
above, pp. 178-95, here p. 187.
120Paul Ehrlich to Friedrich Althoff, Aug. 1903, in
NachlassAlthoffB,GstAPK. VI. HA, Rep.92, No. 33,
pp. 142-3, esp. p. 142.
121Crist andTauber, op. cit., note 97 above, p. 333.
Crist and Tauber also point out that Ehrlich never
abandonded his side-chain theory; see ibid., p. 325.
122For Ehrlich's extremely sensitive reaction to
critics,seealsothemoreorlesshagiographicaccountof
Walter Greiling, Im Banne derMedizin. Paul Ehrlich.
Leben und Werk, Dusseldorf, Econ, 1954, pp. 120-2.
Research onchemotherapy was above all carried out in
the Georg-Speyer House, newly erected in 1906. This
Institute was attached to Ehrlich's Institute. See
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Although he was very enthusiastic aboutthe receptors, there are indications in Ehrlich's
correspondence that he was notentirely satisfied with his situation. Even in the last Berlin
years attheInstitute inSteglitz, namely after 1898, Ehrlich wasfacedwiththeproblem that
as head of a theoretical institute he had no patients.123 The reason for his wish to have
patients was theoftenrepeated intention that "afterhavingworkedentirely onquestions of
serumtherapyforsuch along time, I wanttoturn abittomyoldpetsubjectagain, whichis
histological andbiological staining"; or, expressed in another way: "Afterthe long period
ofimmunological magic Iamnowagaingettingaroundtofocusagainalittlebitonthedyes
as my old pet subject ..,, 124 Although predominantly publishing on side-chains between
1897 and 1905 (twenty-eight papers), he did not stop publishing on dye-stuffs and their
clinical application (six papers) as well as on purely chemical problems (two papers).'25
Even in his immunological studies he did not hesitate to draw parallels with staining
processes. Ehrlich was not very keen to work as a physician again, but rather to carry
out the clinical testing of potential drugs. In the following period, he pre-tested dyes on
animals, examinedthesideeffectsandthereaftersentthemtoclinicianswiththerequestthat
they perform therapeutic human experiments. Ehrlich ordered the dye stuffs from phar-
maceuticalcompanies.Thenhearrangedforthemtobepackedintocapsulesbeforehanding
them over to physicians. This was meant to simplify the application to patients.126 The
bottleneck in this system were the patients, and in the following years Ehrlich constantly
beggedclinicians toperformtherapeuticexperiments. Theproblemforcedhimtogobackto
thoseheknewwell, forexamplehisoldfriendAlbertNeisser(1855-1916), adermatologist
inBreslau. In 1898EhrlichwantedNeissertoadministersomeofhisdyestopatients.These
dyes had already been tested on rabbits and hares, and ha,d been well-tolerated. Ehrlich
recommended a slow increase in the dosage, "first of all in cases of headaches, vague
rheumatic plagues, gonorrhoea andcystitis".127 Neisser was willing to test the dye "bril-
liant blue" on patients. In November 1898, Ehrlich became pushy and urged Neisser to
speed up the trials: "After all, however, it is not so difficult-considering your great
experience with these things-to find the approximate dosage bene tolerata".128 Neisser,
who was then involved in a scandal about his performance of human experiments on
'Das Speyer-Haus in Frankfurt a.M.' (Berliner
Klinische Wochenschrift, 1906), in Nachlass AlthoffA
I, GStA PK. VI. HA, Rep. 92, No. 258, p. 66.
123Liebenau comments that the Institute in
Frankfurt gave Ehrlich the opportunity to conduct
"controlled bedside trials". Besides the problem of
using modem terms and methods anachronistically, it
should be remembered that Ehrlich was no longer
attached to a clinical unit and that he relied on clinical
colleagues to perform therapeutic human experi-
mentation. See Liebenau, op. cit., note 46 above, p. 70.
124 ... nachdem ich so lange serumtherapeutische
fragenfastausschliesslichbearbeitethabe, michwieder
etwas mehr meinem alten lieblingsgebiet theorie der
histologischen und biologischen farbung
zuzuwenden."; "Nach dem langen immunitats zauber
komme ichjetzt wieder dazu, mich meinem alten
lieblingsgebiet der farbstoffe wieder etwas
zuzuwenden .. .". See Paul Ehrlich to the Badische
Anilin- und Sodafabrik, Ludwigshafen, Nov. 15,
1898; Paul Ehrlich to Nietzki, 24 Dec. 1898, in Copir
Buch II. Direktor, 11 Nov. 1898 to 21 Feb. 1899,
box 4, series I, (3)-l, 2, 4, pp. 69, 242, Paul Ehrlich
Collection, RUA, RAC.
125See Himmelweit (ed.), vols. 1-3, op. cit., note4
above.
126See especially Ehrlich's letters in Copir
Buch II. Direktor, 11 Nov. 1898 to 21 Feb. 1899,
box 4, series I, (3)-l, 2, 4, Paul Ehrlich Collection,
RUA, RAC.
127..*. zunachst bei kopfschmerzen, vagen rheu-
matoiden seuchen, gonorrhoe und cystitis." See Paul
Ehrlich to Albert Neisser, no date, in ibid., pp. 93-4.
128"Schliesslich ist es doch auch wohl nicht gar
zu schwer-bei Eurer grossen ubung in diesen din-
gen-die ungefahre dosis bene tolerata heraus zu
bekommen". See Paul Ehrlich to Albert Neisser, 30
Nov. 1898, in ibid., p. 128.
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prostitutesandchildrenwithoutinformationandconsent,testedseveraldyesforEhrlichand
discussed with himthepatientschosen.129 Othercolleagues werenotashelpful asNeisser.
Ehrlich repeatedly requested them to test his substances. Even if the clinician was in
principle prepared to undertake the experiments, Ehrlich had to press forcefully for
tests to be done and the results reported. The system did not work well and from June
1899 Ehrlich showed signs of frustration. He remarked to a colleague that "all these
gentlemen undertake the staining therapy more or less to do me a favour but not out of
deep conviction,.130
Finally, dye testing appears to have been a futile attempt to restore the old Charite
conditions, where laboratory work and animal experimentation could be linked with
clinical expertise. Ehrlich's favourite style of work was so well-known that in 1899 the
administration ofthecityofFrankfurtfearedthatthepatients ofthecityhospitals wouldbe
"used for experimental purposes".'3' But what was left during his first years in Frankfurt
were the merely theoretical studies on the receptors, based on animal trials and test tubes.
Although basically satisfied with his independent position and his working conditions,'32
Ehrlich also detailed the drawbacks when he described his work on the receptors in 1901:
"Because Imyselfamnotinaposition toperform suchinvestigations onalargenumberof
patients, Ithoughtittobemydutytoclarifymypointofviewandthiswaytolaythebasisof
the work in a field whose importance for pathology and therapy presumably will be fully
acknowledged only after many years".'33 In 1905, this argument was essentially repeated
when he explained that he had done his work and that "more new and successful work"
could only be done by "specialists, who have the necessary clinical and pathological
material".'34 This did not mean that Ehrlich wanted to become a full clinician: in the
same year, presumably because ofresponsibilities towardshisInstitute, herejectedthecall
129Paul Ehrlich to Albert Neisser, 9 Dec. 1898; 7
Jan. 1899, in ibid., pp. 178, 179-80, esp. pp. 180, 299.
See also Barbara Elkeles, 'Medizinische
Menschenversuche gegen Ende des 19. Jahrhunderts
und der Fall Neisser: Rechtfertigung und Kritik einer
wissenschaftlichen Methode', Medizinhist. J., 1985,
20: 135-48; idem, Der moralische Diskurs iuber das
medizinischeMenschenexperimentim19.Jahrhundert,
Stuttgart and New York, Fischer, 1996, esp. pp.
190-206.
13 . .... alle diese herren treiben die farbentherapie
eigentlich mehr aus gefalligkeit mir gegenuber, als
ausinnereruberzeugung." SeePaulEhrlichtoIwanoff,
Petrowsk, 30June 1899, inCopirBuchIII. Ehrlich, 21
Feb. 1899 to 31 Jul. 1899, box 5, series I, (3)-l, 2, 4,
pp. 398, 399-402, 403, esp. pp. 398, 399, Paul Ehrlich
Collection, RUA, RAC.
131Carl Weigert to Paul Ebrlich, 27 Mar. 1897, in
Nachlass Althoff A I, GstA PK. VI. HA, Rep. 92, No.
258,pp. 15-16,esp.p. 15.Inreturnforthecontributions
of the city of Frankfurt to the erection ofEhrlich's
Institute, Ehrlichhadtoexaminebody fluids andorgan
specimens from patients of the city hospital. See
Baumler, op. cit., note 5 above, pp. 113-14; Paul
Ehrlich, 'Das Konigliche Institut fur experimentelle
Therapie zu Frankfurt a.M.', Festschrift zum XIV.
Internationalen KongrefifirHygiene und
Demographie, Berlin 1907, dargeboten von dem
PreufJischenMinisterdergeistlichen, Unterrichts- und
Medizinalangelegenheiten, Jena, Fischer, 1907, in
NachlassAlthoffB,GStAPK. VI.HA,Rep.92,No. 33,
pp. 244-55, esp. pp. 251-53. His cousin Carl Weigert
persuaded Frankfurt's administration to agree to
Ehrlich's and Althoff's plans.
'32Paul Ehrlich to Friedrich Althoff, 23 Feb. 1900,
in Nachlass AlthoffB, GStA PK. VI. HA, Rep. 92,
No. 33, pp. 114-15.
133"Da ich selbst nicht in der Lage bin, derartige
Untersuchungen an einem grosseren Krankenmaterial
durchzuflihren, habe ich es furmeine Pflicht gehalten,
dieGesichtspunkteklarzulegenundsodieBasisfurdie
Bearbeitung eines Gebietes zu schaffen, dessen
Bedeutung fiur die Pathologie und Therapie vielleicht
erst nach Jahren voll gewurdigt werden wird." See
Ehrlich, op. cit., note 86 above, p. 315.
'34Paul Ehrlich to Friedrich Althoff, 1 Jan. 1905,
in Nachlass AlthoffB,GStA PK. VI. HA,Rep. 92, No.
33, pp. 150-6, on p. 153.
353Cay-Ruidiger Prull
tobecome directoroftheFirstMedical Clinic inVienna.'35 Buthewantedtobe attachedto
clinical facilities as a laboratory worker. Ehrlich continued to be dependent on distant
collaboration with physicians in respect of drug trials-for example with his teacher
Koch.'36 And finally it was partly due to the revival of the old idea of the therapeutic
application ofdyes, theapplicationoftrypanredtotrypanosomes, thatEhrlich successfully
developed Salvarsan. In combination with the old ideas, the theoretical work on the side-
chains and receptors had its practical impact.'37
Paul Ehrlich, Pharmacology and the Receptors
Contrary to the current perceptions ofEhrlich's research progression, there was a leit-
motif, but no well developed master plan to lead him directly to the receptors. At the
beginning of his Berlin period, under the clinician Friedrich Theodor Frerichs, Ehrlich
advocatedaconceptwhichdidnotrely ontheintricateconstructionoftheside-chaintheory
as apredecessorofthereceptorconcept. Ehrlich'sprovisional ideas onthetheoretical basis
ofhis workdidnotplay animportantroleinhisobjective ofthese years, namely toachieve
practical therapeuticresults. These couldbeachievedbycombininghisfavourite, chemical
laboratory work, with animal experimentation andtherapeutic humanexperimentation in a
pragmatic way, and there was no need to deepen knowledge ofthe side-chains. The end of
Ehrlich'scareerintheclinicalcontext, whichwasprincipally causedbythe suddendeathof
Frerichs, shouldbeconsideredmoreseriouslyasadecisivebreakinEhrlich'slifethanithas
been hitherto. He tried to use the laboratory, his most important work place, as a starting
pointtorebuildtheoldsystem. UnderKoch,heorganizedandperformedclinicaltrialsafter
1895. ButEhrlichhadtoreorientate. Heneededtoachieve asecurepositionwithintherigid
frameworkofinstitutionalized Germanmedicine, which was mainlyuniversity based. This
objective was complicated by his Jewish faith, and he had to grasp Behring's and then
Althoffs offers. But Ehrlich remained indebted to the ideas ofJulius Cohnheim on func-
tional (experimental) pathology as related to clinical problems.'38 In Germany, where the
oldermedicaldisciplineswerewellestablishedfromabout 1900,thismeantsittingbetween
thechairsofpathology onone sideandclinicaldisciplines ontheother. Althoughburdened
with problems, Ehrlich made rigorous efforts to initiate the testing ofdyes with the help of
clinical colleagues even after he started to work in earnest on the side-chain and receptor
theory.Theseeffortswerenotsuccessful, andinthissituationthetheoreticalevidenceofhis
approach became more important than ever. In his institute, Ehrlich concentrated on con-
structing a comprehensive theory, not only of immunological processes but also of the
human metabolism in general. The final aim continued to be the practical application to
man,basedonlaboratoryresearch. Butatfirst,Ehrlichwascontrainedtosatisfyhimself, the
scientific community andthepublic with vague assumptions aboutthe future effectiveness
ofhis concept in modem medicine. The critics ofthe side-chain and receptor theory, who
raised their voices shortly after Ehrlich had developed his ideas, stimulated the further
135Georg Joannovics, 'Paul Ehrlich 1854-1915', 137Parascandola, op. cit., note 11 above, esp. p. 30.
Wiener Klinische Wochenschrift, 1915, 28: 937-42, See also Ehrlich's papers on chemotherapy, especially
esp. p. 940. the Harben Lectures of 1907, in Himmelweit (ed.),
136Munch and Biel, op. cit., note 112 above, vol. 3, op. cit., note 4 above.
pp. 13-14. 138Jokl, op. cit., note 5 above, pp. 972-4.
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consolidation of his theory, and they dragged Ehrlich more and more into the pluralistic
receptor world. The development of the receptor concept was, therefore, a construction
dependant on the combination ofevents in his private and public life and in his academic
career. This analysis corresponds with recentbiographical research in general historiogra-
phy which has tried to explain the life ofscientists on the basis oftheir social and cultural
environment.139
This revisionist account of Ehrlich and his receptors helps us to understand why his
receptortheorywasnotatoncegenerally acceptedinpharmacologyanditcomplements the
existing literature on the history ofpharmacology.140 Ehrlich's receptorconcept was basic
research, hard to understand, and its technical possibilities in his time were limited. But
thereareotherreasons.Despitehisreputation, Ehrlichwasnopharmacologistandhedidnot
agree with the mainstream of pharmacological research. This was devoted mainly to
physical or physico-chemical views of the character of drug-binding. It was based on
the idea of a mechanical connection between dye-stuff and cell. For pharmacologists
such as Walther Straub (1874-1944), one ofthe most prominent German pharmacologists
in the first halfofthe twentieth century, such physical properties as solubility and surface
tension played aprincipal role in the effect ofa substance on a cell. Arthur Cushny (1866-
1926), oneofthe mostinternationally influential pharmacologists attheturn ofthecentury,
atleastrestrictedtheimpactofstructuralchemistryintermsofaphysico-chemical view.141
Above all, the doubts of contemporary pharmacologists were fuelled by the theoretical
character of Ehrlich's ideas,142 which could be promoted only with the help of a vast
propaganda apparatus. Although the side-chain theory delivered the basis for Ehrlich's
ownresearch oncancerandchemotherapy,143 andwas seenbycolleagues as aninspiration
for further work, there was at first no evidence for its usefulness to immunology or phar-
macology in general.' 44As a construction,
Ehrlich's social biography, his personality
139Margit Szollosi-Janze, FritzHaber, 1868-1934.
Eine Biographie, Munich, Beck, 1998. See above all
the introduction on pp. 9-22; idem, 'Lebens-
Geschichte-Wissenschaftsgeschichte. Vom Nutzen
der Biographie fur Geschichtswissenschaft und
Wissenschaftsgeschichte', Berichte zur
Wissenschaftsgeschichte, 2000, 23: 17-35; Christoph
Gradmann, 'Leben in der Medizin: Zur Aktualitat von
Biographie und Prosopographie in der
Medizingeschichte', in Norbert Paul and Thomas
Schlich (eds), Medizingeschichte, Aufgaben,
Probleme, Perspektiven, Frankfurt and New York,
Campus, 1998, pp. 243-65.
140See Parascandola and Jasensky, op. cit., note 2
above; Parascandola, op. cit., note 2 above.
141John Parascandola, 'The controversy over
structure-activity relationships in the early twentieth
century', Pharm. Hist., 1974,16: 54-63,esp. pp. 55-6.
142This was registered already by contemporaries,
see,forexample, 'Obituary. WirklicherGeheimratPaul
Ehrlich', Lancet, 1915, i: 525-6, esp. p. 525. It is
considered also in the secondary literature on the
receptors; see, for example, Rubin, op. cit., note 102
which came into existence as a product of
and his scientific career development, the
above, pp. 400-7; Cambrosio, Jacobi, and Keating,
op. cit., note 114 above, pp. 662-99.
143Ehrlich sawthe side-chain theory as a "unifying
bond" (einigendesBand)oftheworkofalldepartments
in theFrankfurt Institute. SeeEhrlich, op. cit., note 131
above,p.251. Seealso 'Paperonthecancerresearchof
Ehrlich', anonymous, Frankfurt, 7 April 1906, in
Nachlass Althoff A I, GstA PK. VI. HA, Rep. 92,
No. 258, pp. 32-8, hereesp. pp. 37-8; Lenoire, op. cit.,
note 22 above, pp. 79-82.
'44See Paul Ehrlich and Hans Sachs, 'Kritiker der
Seitenkettentheorie im Lichte ihrer experimentellen
und literarischen Forschung. Ein Kommentar zu den
Arbeiten von Bang und Forssmann' (Munchener
Medizinische Wochenschrift, 1909), in Himmelweit
(ed.), vol. 2, op. cit., note 4 above, pp. 448-63; Paul
Ehrlich and Hans Sachs, 'Ist die Ehrlichsche
Seitenkettentheorie mit den tatsachlichen
Verhaltnissen vereinbar? Bemerkungen zu der II.
Mitteilung von Bang und Forssmann' (Munchener
Medizinische Wochenschrift, 1910), in ibid.,
pp. 464-71; Paul Ehrlich to Friedrich Althoff, 18 Mar.
presumably 1907, inNachlass AlthoffB, GstAPK. VI.
355Cay-Riidiger Prull
receptors were the final stage of a process spiralling up into the enterprise of theoretical
research. Withhispropaganda management andhisexperimental system, Ehrlichwas able
successfullytoadaptthehypotheticalreceptorsystemtoeverynewchallenge. Thedecision
whethertojoinEhrlich orto oppose him, whetherto be a "pluralist" ora "unitarian", had
parallels with religious profession. One had to believe in "the theory" or to abandon it
totally.145 It was very much shaped by its creator, who tried to increase its credibility
through a combination of persuasion and force. At this point, it could not be foreseen
that the "discovery" of the receptors would become so central to pharmacology, and
biomedicine in general, after 1945.
HA, Rep. 92, No. 33,p. 329. Althoughthebasic ideaof
chemical specificity survived in immunology after the
death of the master, this was not true in general for
his whole receptor concept. This remained controver-
sial as Ehrlich's mature theory could not be used to
explain the action of the living organism, see
Mazumdar, op. cit., note 65 above, pp. 18-21; also
William Bulloch, The history ofbacteriology, 2nded.,
London, Oxford University Press, (1938) 1960,
pp. 275-9.
145See also August Wassermann, 'Paul Ehrlich',
Munchener Medizinische Wochenschrift, 1909, 56:
245-7, esp. 247.
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